0001285543false--12-31Q120220.10100000001000000000000.000140000000009555150789553802251003330.10100000000366673666736667The
Company and BST have a management agreement pursuant to which BST
shall remit a management fee of $36,000 per month to the Company,
and when BST reaches a milestone of $1,000,000 in financing, an
additional management fee of $5,000,000 shall be owed to the
Company, payable monthly over three
years8950005030008950002680003100001639000150000126300015000001348530.11210.11210.11211121250000112125000000012855432022-01-012022-03-310001285543us-gaap:SubsequentEventMembersrt:MaximumMember2022-05-012022-05-310001285543us-gaap:SubsequentEventMembersrt:MinimumMember2022-05-012022-05-310001285543us-gaap:SubsequentEventMember2022-05-012022-05-310001285543us-gaap:SubsequentEventMember2022-04-012022-04-300001285543sfor:OptionsOutstandingMember2022-03-310001285543sfor:OptionExercisablesMembersfor:ExercisePricesFiveMember2022-03-310001285543sfor:OptionsOutstandingMembersfor:ExercisePricesThreeMember2022-03-310001285543sfor:OptionsOutstandingMembersfor:ExercisePricesTwoMember2022-03-310001285543sfor:OptionsOutstandingMembersfor:ExercisePricesOneMember2022-03-310001285543sfor:OptionExercisableMembersfor:ExercisePricesOneMember2022-03-310001285543sfor:OptionExercisableMember2022-01-012022-03-310001285543sfor:OptionsOutstandingMember2022-01-012022-03-310001285543sfor:OptionExercisablesMembersfor:ExercisePricesFiveMember2022-01-012022-03-310001285543sfor:OptionsOutstandingMembersfor:ExercisePricesFiveMember2022-01-012022-03-310001285543sfor:OptionExercisableMembersfor:ExercisePricesFourMember2022-01-012022-03-310001285543sfor:OptionExercisableMembersfor:ExercisePricesThreeMember2022-01-012022-03-310001285543sfor:OptionsOutstandingMembersfor:ExercisePricesThreeMember2022-01-012022-03-310001285543sfor:OptionExercisableMembersfor:ExercisePricesTwoMember2022-01-012022-03-310001285543sfor:OptionsOutstandingMembersfor:ExercisePricesTwoMember2022-01-012022-03-310001285543sfor:OptionExercisableMembersfor:ExercisePricesOneMember2022-01-012022-03-310001285543sfor:OptionsOutstandingMembersfor:ExercisePricesOneMember2022-01-012022-03-310001285543sfor:OptionExercisableMembersfor:ExercisePricesMember2022-01-012022-03-310001285543sfor:OptionsOutstandingMembersfor:ExercisePricesMember2022-01-012022-03-310001285543sfor:OptionsOutstandingMembersfor:ExercisePricesFourMember2022-01-012022-03-310001285543sfor:OptionExercisableMember2022-03-310001285543sfor:OptionsOutstandingMembersfor:ExercisePricesFiveMember2022-03-310001285543sfor:OptionExercisableMembersfor:ExercisePricesFourMember2022-03-310001285543sfor:OptionsOutstandingMembersfor:ExercisePricesFourMember2022-03-310001285543sfor:OptionExercisableMembersfor:ExercisePricesThreeMember2022-03-310001285543sfor:OptionExercisableMembersfor:ExercisePricesTwoMember2022-03-310001285543sfor:OptionExercisableMembersfor:ExercisePricesMember2022-03-310001285543sfor:OptionsOutstandingMembersfor:ExercisePricesMember2022-03-310001285543sfor:MaximumsMember2022-01-012022-03-310001285543sfor:MinimumsMember2022-01-012022-03-310001285543sfor:WarrantsMember2022-03-310001285543sfor:WarrantsMembersfor:MaximumsMember2022-01-012022-03-310001285543sfor:WarrantsFourMembersfor:MinimumsMember2022-01-012022-03-310001285543sfor:WarrantsMember2022-01-012022-03-310001285543sfor:WarrantFourMember2022-01-012022-03-310001285543sfor:WarrantThreeMember2022-01-012022-03-310001285543sfor:WarrantTwoMember2022-01-012022-03-310001285543sfor:WarrantOneMember2022-01-012022-03-310001285543sfor:WarrantInFiveMember2022-01-012022-03-310001285543srt:MaximumMember2022-01-012022-03-310001285543srt:MinimumMember2022-01-012022-03-310001285543sfor:LitigationFundingAgreementMembersfor:TheriumIncAndVGLCapitalLLCMember2017-09-012017-09-060001285543sfor:PromissoryNoteVariousPartiesMembersfor:RelatedPartyMember2019-01-012019-12-310001285543sfor:UnsecuredConvertibleNotesPayableMember2018-01-012018-12-310001285543sfor:BSTMember2021-12-310001285543sfor:PromissoryNoteVariousPartiesMembersfor:RelatedPartyMember2019-12-310001285543sfor:ChiefExecutiveOfficersMembersrt:MinimumMember2022-03-310001285543sfor:ChiefExecutiveOfficersMembersrt:MaximumMember2022-03-310001285543sfor:EidLoanMember2020-05-012020-05-150001285543sfor:OneNoteMember2022-01-012022-03-310001285543sfor:OneNoteMember2019-12-310001285543sfor:NotesPayableMember2022-01-012022-03-310001285543sfor:OneNoteMember2021-12-310001285543sfor:OneNoteMember2022-03-310001285543sfor:NotesPayableMember2022-03-310001285543sfor:NotesPayableMember2021-12-310001285543sfor:EidLoanMember2021-12-310001285543sfor:EidLoanMember2022-03-310001285543sfor:ChiefExecutiveOfficersMember2022-01-012022-03-310001285543sfor:ChiefExecutiveOfficersMember2022-03-310001285543sfor:ChiefExecutiveOfficersMember2021-12-310001285543sfor:TwentyZeroFiveMember2022-01-012022-03-310001285543sfor:TwentyZeroFiveMember2021-12-310001285543sfor:TwentyZeroFiveMember2022-03-310001285543sfor:TwentyZeroFiveThroughTwentyZeroFiveMember2021-12-310001285543sfor:TwentyZeroFiveThroughTwentyZeroFiveMember2022-03-310001285543sfor:TwentyZeroFiveThroughTwentyZeroFiveMember2022-01-012022-03-310001285543sfor:RevenuesMembersfor:FourCustomerMember2022-01-012022-03-310001285543sfor:TwoCustomerMemberus-gaap:AccountsReceivableMember2022-01-012022-03-310001285543sfor:OneCustomerMemberus-gaap:AccountsReceivableMember2022-01-012022-03-310001285543sfor:TwoCustomerMembersfor:RevenuesMember2021-01-012021-12-310001285543sfor:OneCustomerMembersfor:RevenuesMember2021-01-012021-12-310001285543sfor:ThreeCustomerMembersfor:RevenuesMember2022-01-012022-03-310001285543sfor:TwoCustomerMembersfor:RevenuesMember2022-01-012022-03-310001285543sfor:OneCustomerMembersfor:RevenuesMember2022-01-012022-03-310001285543sfor:BSTMember2022-01-012022-03-310001285543sfor:BSTMember2022-03-3100012855432021-01-012021-12-310001285543us-gaap:ServiceMember2021-01-012021-03-310001285543us-gaap:SoftwareDevelopmentMember2021-01-012021-03-310001285543us-gaap:ServiceMember2022-01-012022-03-310001285543us-gaap:SoftwareDevelopmentMember2022-01-012022-03-310001285543us-gaap:NoncontrollingInterestMember2022-03-310001285543us-gaap:RetainedEarningsMember2022-03-310001285543us-gaap:AdditionalPaidInCapitalMember2022-03-310001285543sfor:CommonStockParvalue00001Member2022-03-310001285543sfor:SeriesBPreferredStockparvalueZeroTenMember2022-03-310001285543sfor:SeriesAPreferredStocknoparvalueMember2022-03-310001285543us-gaap:NoncontrollingInterestMember2022-01-012022-03-310001285543us-gaap:RetainedEarningsMember2022-01-012022-03-310001285543us-gaap:AdditionalPaidInCapitalMember2022-01-012022-03-310001285543sfor:CommonStockParvalue00001Member2022-01-012022-03-310001285543sfor:SeriesBPreferredStockparvalueZeroTenMember2022-01-012022-03-310001285543sfor:SeriesAPreferredStocknoparvalueMember2022-01-012022-03-310001285543us-gaap:NoncontrollingInterestMember2021-12-310001285543us-gaap:RetainedEarningsMember2021-12-310001285543us-gaap:AdditionalPaidInCapitalMember2021-12-310001285543sfor:CommonStockParvalue00001Member2021-12-310001285543sfor:SeriesBPreferredStockparvalueZeroTenMember2021-12-310001285543sfor:SeriesAPreferredStocknoparvalueMember2021-12-3100012855432021-03-310001285543us-gaap:NoncontrollingInterestMember2021-03-310001285543us-gaap:RetainedEarningsMember2021-03-310001285543us-gaap:AdditionalPaidInCapitalMember2021-03-310001285543sfor:CommonStockParvalue00001Member2021-03-310001285543sfor:SeriesBPreferredStockparvalueZeroTenMember2021-03-310001285543sfor:SeriesAPreferredStocknoparvalueMember2021-03-310001285543us-gaap:NoncontrollingInterestMember2021-01-012021-03-310001285543us-gaap:RetainedEarningsMember2021-01-012021-03-310001285543us-gaap:AdditionalPaidInCapitalMember2021-01-012021-03-310001285543sfor:CommonStockParvalue00001Member2021-01-012021-03-310001285543sfor:SeriesBPreferredStockparvalueZeroTenMember2021-01-012021-03-310001285543sfor:SeriesAPreferredStocknoparvalueMember2021-01-012021-03-3100012855432020-12-310001285543us-gaap:NoncontrollingInterestMember2020-12-310001285543us-gaap:RetainedEarningsMember2020-12-310001285543us-gaap:AdditionalPaidInCapitalMember2020-12-310001285543sfor:CommonStockParvalue00001Member2020-12-310001285543sfor:SeriesBPreferredStockparvalueZeroTenMember2020-12-310001285543sfor:SeriesAPreferredStocknoparvalueMember2020-12-3100012855432021-01-012021-03-310001285543sfor:PreferredStockSeriesBMember2022-03-310001285543sfor:PreferredStockSeriesBMember2021-12-310001285543sfor:PreferredStockSeriesAMember2022-03-310001285543sfor:PreferredStockSeriesAMember2021-12-310001285543us-gaap:SeriesBPreferredStockMember2021-12-310001285543us-gaap:SeriesAPreferredStockMember2021-12-310001285543us-gaap:SeriesBPreferredStockMember2022-03-310001285543us-gaap:SeriesAPreferredStockMember2022-03-3100012855432021-12-3100012855432022-03-3100012855432022-05-16iso4217:USDxbrli:sharesiso4217:USDxbrli:sharesxbrli:pure
UNITED STATES
SECURITIES EXCHANGE COMMISSION
Washington, D.C. 20549
FORM 10-Q
☒
|
QUARTERLY REPORT UNDER SECTION 13 OR 15(d) OF THE
SECURITIES EXCHANGE ACT OF 1934.
|
|
|
|
For the quarterly period ended March 31, 2022
|
☐
|
TRANSITION REPORT UNDER SECTION 13 OR 15(d) OF THE
SECURITIES EXCHANGE ACT OF 1934.
|
|
|
|
For the transition period from _________ to _________
|
STRIKEFORCE TECHNOLOGIES,
INC.
|
(Exact name of registrant as specified in its Charter)
|
Wyoming
|
|
000-55012
|
|
22-3827597
|
(State or other jurisdiction of
incorporation or organization)
|
|
(Commission
file number)
|
|
(I.R.S. Employer
Identification No.)
|
1090 King Georges
Post Road, Suite 603
Edison,
NJ 08837
(Address of Principal Executive Offices)
(732)
661-9641
(Issuer’s telephone number)
Securities registered pursuant to Section 12(b) of the Exchange
Act:
Title of each class
|
|
Name of each exchange
on which registered
|
N/A
|
|
N/A
|
Securities registered pursuant to Section 12(b) of the Act:
Title of each class
|
|
Trading Symbol(s)
|
|
Name of each exchange on which registered
|
Common Stock, $0.0001 par value
|
|
SFOR
|
|
OTCQB
|
Indicate by check mark if the registrant is not required to file
reports pursuant to Section 13 or Section 15(d) of the Act. ☐ Yes
No ☒
Check whether the issuer (1) filed all reports required to be filed
by Section 13 or 15(d) of the Exchange Act during the past 12
months (or for such shorter period that the registrant was required
to file such reports), and (2) has been subject to such filing
requirements for the past 90 days. Yes ☒ No
☐
Indicate by check mark whether the registrant has submitted
electronically, every Interactive Data File required to be
submitted pursuant to Rule 405 of Regulation S-T (§232.405 of this
chapter) during the preceding 12 months (or for such a shorter
period that the registrant was required to submit and post such
files). Yes ☒ No ☐
Indicate by check mark whether the registrant is a large
accelerated filer, an accelerated filer, a non-accelerated filer,
smaller reporting company, or an emerging growth company. See the
definitions of “large accelerated filer,” “accelerated filer,”
“smaller reporting company,” and “emerging growth company” in Rule
12b–2 of the Exchange Act.
Large accelerated filer
|
☐
|
Accelerated filer
|
☐
|
Non-accelerated Filer
|
☐
|
Smaller reporting company
|
☒
|
|
|
Emerging growth company
|
☐
|
If an emerging growth company, indicate by check mark if the
registrant has elected not to use the extended transition period
for complying with any new or revised financial accounting
standards provided pursuant to Section 7(a)(2)(B) of the Securities
Act. ☐
Indicate by check mark whether the registrant is a shell company
(as defined in Rule 12b-2 of the Act.) Yes ☐ No ☒
Indicate the number of shares outstanding of each of the issuer’s
classes of common stock, as of the latest practicable date.
Class
|
|
Outstanding at May 16, 2022
|
Common stock, $0.0001 par value
|
|
1,005,611,161
|
Indicate the number of shares outstanding of each of the issuer’s
classes of preferred stock, as of the latest practicable date.
Class
|
|
Outstanding at May 16, 2022
|
Preferred stock, Series A, no par value
|
|
3
|
Class
|
|
Outstanding at May 16, 2022
|
Preferred stock, Series B, $0.10 par value
|
|
36,667
|
Transitional Small Business Disclosure Format
Yes ☐ No ☒
Documents Incorporated By Reference
None
STRIKEFORCE TECHNOLOGIES, INC.
INDEX TO FORM 10-Q FILING
MARCH 31, 2022
TABLE OF CONTENTS
PART I
ITEM 1. CONDENSED CONSOLIDATED FINANCIAL
STATEMENTS AND NOTES TO INTERIM CONDENSED CONSOLIDATED FINANCIAL
STATEMENTS
STRIKEFORCE TECHNOLOGIES,
INC.
CONDENSED CONSOLIDATED BALANCE SHEETS
|
|
March 31, 2022
|
|
|
December 31, 2021
|
|
|
|
(Unaudited)
|
|
|
|
|
ASSETS
|
|
|
|
|
|
|
Current Assets:
|
|
|
|
|
|
|
Cash (includes VIE balances of $1,000 and $1,000, respectively)
|
|
$ |
974,000 |
|
|
$ |
2,084,000 |
|
Accounts receivable, net
|
|
|
14,000 |
|
|
|
24,000 |
|
Prepaid expenses
|
|
|
2,000 |
|
|
|
13,000 |
|
|
|
|
|
|
|
|
|
|
Total current assets
|
|
|
990,000 |
|
|
|
2,121,000 |
|
|
|
|
|
|
|
|
|
|
Property and equipment, net
|
|
|
24,000 |
|
|
|
- |
|
Operating lease right-of-use asset
|
|
|
94,000 |
|
|
|
107,000 |
|
Other assets
|
|
|
12,000 |
|
|
|
12,000 |
|
|
|
|
|
|
|
|
|
|
Total Assets
|
|
$ |
1,120,000 |
|
|
$ |
2,240,000 |
|
|
|
|
|
|
|
|
|
|
LIABILITIES AND STOCKHOLDERS’ DEFICIT
|
|
|
|
|
|
|
|
|
Current Liabilities:
|
|
|
|
|
|
|
|
|
Accounts payable and accrued expenses (includes VIE balances of
$4,000 and $2,000, respectively)
|
|
$ |
1,042,000 |
|
|
$ |
996,000 |
|
Convertible notes payable (including $895,000 and $895,000 in
default, respectively)
|
|
|
1,378,000 |
|
|
|
1,398,000 |
|
Convertible notes payable - related parties
|
|
|
268,000 |
|
|
|
268,000 |
|
Notes payable (including $1,965,000 and $1,972,000 in default,
respectively) (includes VIE balances of $310,000 and $310,000,
respectively)
|
|
|
1,965,000 |
|
|
|
1,972,000 |
|
Notes payable - related parties
|
|
|
693,000 |
|
|
|
693,000 |
|
Accrued interest (including $1,527,000 and $1,497,000 due to
related parties, respectively) (includes VIE balances of $126,000
and $120,000, respectively)
|
|
|
5,577,000 |
|
|
|
5,477,000 |
|
Contingent payment obligation
|
|
|
1,500,000 |
|
|
|
1,500,000 |
|
VIE Financing obligation
|
|
|
1,263,000 |
|
|
|
1,263,000 |
|
Operating lease liability, current portion
|
|
|
55,000 |
|
|
|
39,000 |
|
|
|
|
|
|
|
|
|
|
Total current liabilities
|
|
|
13,741,000 |
|
|
|
13,606,000 |
|
|
|
|
|
|
|
|
|
|
Notes payable, long-term portion
|
|
|
150,000 |
|
|
|
150,000 |
|
Operating lease liability, long term portion
|
|
|
43,000 |
|
|
|
73,000 |
|
|
|
|
|
|
|
|
|
|
Total Liabilities
|
|
|
13,934,000 |
|
|
|
13,829,000 |
|
|
|
|
|
|
|
|
|
|
Commitments and Contingencies
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Stockholders’ Deficit
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Series A Preferred stock, no par value; 100 shares
authorized; 3 shares issued and outstanding
|
|
|
987,000 |
|
|
|
987,000 |
|
Series B Preferred stock par value $0.10: 100,000,000 shares
authorized; 36,667 shares issued and outstanding
|
|
|
4,000 |
|
|
|
4,000 |
|
Preferred stock series not designated par value $0.10: 10,000,000
shares authorized; none issued or outstanding
|
|
|
- |
|
|
|
- |
|
Common stock par value $0.0001: 4,000,000,000 shares authorized;
955,515,078 and 955,380,225 shares issued and outstanding,
respectively
|
|
|
96,000 |
|
|
|
96,000 |
|
Additional paid-in capital
|
|
|
61,430,000 |
|
|
|
59,788,000 |
|
Accumulated deficit
|
|
|
(74,455,000 |
) |
|
|
(71,595,000 |
) |
Total StrikeForce Technologies, Inc. stockholders’ deficit
|
|
|
(11,938,000 |
) |
|
|
(10,720,000 |
) |
Noncontrolling interest in consolidated subsidiary
|
|
|
(876,000 |
) |
|
|
(869,000 |
) |
|
|
|
|
|
|
|
|
|
Total Stockholders’ Deficit
|
|
|
(12,814,000 |
) |
|
|
(11,589,000 |
) |
|
|
|
|
|
|
|
|
|
Total Liabilities and Stockholders’ Deficit
|
|
$ |
1,120,000 |
|
|
$ |
2,240,000 |
|
See accompanying notes to the condensed consolidated financial
statements.
STRIKEFORCE TECHNOLOGIES,
INC.
CONDENSED CONSOLIDATED STATEMENTS OF
OPERATIONS
|
|
For the Three Months Ended
|
|
|
|
March 31,
2022
|
|
|
March 31,
2021
|
|
|
|
(Unaudited)
|
|
|
(Unaudited)
|
|
|
|
|
|
|
|
|
Revenue
|
|
$ |
32,000 |
|
|
$ |
46,000 |
|
|
|
|
|
|
|
|
|
|
Operating expenses:
|
|
|
|
|
|
|
|
|
Cost of revenue
|
|
|
10,000 |
|
|
|
3,000 |
|
Selling, general and administrative expenses
|
|
|
2,636,000 |
|
|
|
5,628,000 |
|
Research and development
|
|
|
154,000 |
|
|
|
145,000 |
|
|
|
|
|
|
|
|
|
|
Total operating expenses
|
|
|
2,800,000 |
|
|
|
5,776,000 |
|
|
|
|
|
|
|
|
|
|
Loss from operations
|
|
|
(2,768,000 |
) |
|
|
(5,730,000 |
) |
|
|
|
|
|
|
|
|
|
Other expense:
|
|
|
|
|
|
|
|
|
Interest expense (including $30,000 and $31,000 to related parties,
respectively)
|
|
|
(99,000 |
) |
|
|
(128,000 |
) |
Debt discount amortization
|
|
|
- |
|
|
|
(23,000 |
) |
Financing costs
|
|
|
- |
|
|
|
(3,239,000 |
) |
Change in fair value of derivative liabilities
|
|
|
- |
|
|
|
(219,000 |
) |
Loss on extinguishment of debt, net
|
|
|
- |
|
|
|
(607,000 |
) |
|
|
|
|
|
|
|
|
|
Other expense
|
|
|
(99,000 |
) |
|
|
(4,216,000 |
) |
|
|
|
|
|
|
|
|
|
Net loss
|
|
|
(2,867,000 |
) |
|
|
(9,946,000 |
) |
|
|
|
|
|
|
|
|
|
Net loss attributable to noncontrolling interest
|
|
|
7,000 |
|
|
|
7,000 |
|
|
|
|
|
|
|
|
|
|
Net loss attributable to StrikeForce Technologies, Inc.
|
|
$ |
(2,860,000 |
) |
|
$ |
(9,939,000 |
) |
|
|
|
|
|
|
|
|
|
Net loss per common share
|
|
|
|
|
|
|
|
|
-Basic and diluted
|
|
$ |
(0.00 |
) |
|
$ |
(0.01 |
) |
|
|
|
|
|
|
|
|
|
Weighted average common shares outstanding
|
|
|
|
|
|
|
|
|
-Basic and diluted
|
|
|
955,465,906 |
|
|
|
777,075,644 |
|
See accompanying notes to the condensed consolidated financial
statements.
STRIKEFORCE TECHNOLOGIES,
INC.
CONDENSED CONSOLIDATED STATEMENTS OF CHANGES IN
STOCKHOLDERS’ DEFICIT
FOR THE THREE MONTHS ENDED MARCH 31, 2022 AND 2021
(Unaudited)
Three months ended March 31, 2022
|
|
Series A
Preferred stock,
no par value
|
|
|
Series B
Preferred stock,
par value $0.10
|
|
|
Common stock,
par value
$0.0001
|
|
|
Additional
Paid-in
|
|
|
Accumulated
|
|
|
Noncontrolling
|
|
|
Total
Stockholders’
|
|
|
|
Shares
|
|
|
Amount
|
|
|
Shares
|
|
|
Amount
|
|
|
Shares
|
|
|
Amount
|
|
|
Capital
|
|
|
Deficit
|
|
|
Interest
|
|
|
Deficit
|
|
Balance at January 1, 2022
|
|
|
3 |
|
|
$ |
987,000 |
|
|
|
36,667 |
|
|
$ |
4,000 |
|
|
|
955,380,225 |
|
|
$ |
96,000 |
|
|
$ |
59,788,000 |
|
|
$ |
(71,595,000 |
) |
|
$ |
(869,000 |
) |
|
$ |
(11,589,000 |
) |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Fair value of common stock issued for services
|
|
|
- |
|
|
|
- |
|
|
|
- |
|
|
|
- |
|
|
|
134,853 |
|
|
|
- |
|
|
|
6,000 |
|
|
|
- |
|
|
|
- |
|
|
|
6,000 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Fair value of vested options
|
|
|
- |
|
|
|
- |
|
|
|
- |
|
|
|
- |
|
|
|
- |
|
|
|
- |
|
|
|
1,636,000 |
|
|
|
- |
|
|
|
- |
|
|
|
1,636,000 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Net loss
|
|
|
- |
|
|
|
- |
|
|
|
- |
|
|
|
- |
|
|
|
- |
|
|
|
- |
|
|
|
- |
|
|
|
(2,860,000 |
) |
|
|
(7,000 |
) |
|
|
(2,867,000 |
) |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Balance at March 31, 2022 (unaudited)
|
|
|
3 |
|
|
$ |
987,000 |
|
|
|
36,667 |
|
|
$ |
4,000 |
|
|
|
955,515,078 |
|
|
$ |
96,000 |
|
|
$ |
61,430,000 |
|
|
$ |
(74,455,000 |
) |
|
$ |
(876,000 |
) |
|
$ |
(12,814,000 |
) |
See accompanying notes to the condensed consolidated financial
statements.
STRIKEFORCE TECHNOLOGIES, INC.
CONDENSED CONSOLIDATED STATEMENTS OF CHANGES IN
STOCKHOLDERS’ DEFICIT
FOR THE THREE MONTHS ENDED MARCH 31, 2022 AND 2021
(Unaudited)
Three months ended March 31, 2021
|
|
Series A
Preferred stock,
no par value
|
|
|
Series B
Preferred stock,
par value $0.10
|
|
|
Common stock,
par value
$0.0001
|
|
|
Additional
Paid-in
|
|
|
Accumulated
|
|
|
Noncontrolling
|
|
|
Total
Stockholders’
|
|
|
|
Shares
|
|
|
Amount
|
|
|
Shares
|
|
|
Amount
|
|
|
Shares
|
|
|
Amount
|
|
|
Capital
|
|
|
Deficit
|
|
|
Interest
|
|
|
Deficit
|
|
Balance at January 1, 2021
|
|
|
3 |
|
|
$ |
987,000 |
|
|
|
36,667 |
|
|
$ |
4,000 |
|
|
|
718,263,338 |
|
|
$ |
72,000 |
|
|
$ |
39,814,000 |
|
|
$ |
(54,396,000 |
) |
|
$ |
(823,000 |
) |
|
$ |
(14,342,000 |
) |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Common stock issued for cash
|
|
|
- |
|
|
|
- |
|
|
|
- |
|
|
|
- |
|
|
|
38,116,450 |
|
|
|
4,000 |
|
|
|
1,445,000 |
|
|
|
- |
|
|
|
- |
|
|
|
1,449,000 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Fair value of common stock issued for services
|
|
|
- |
|
|
|
- |
|
|
|
- |
|
|
|
- |
|
|
|
128,527 |
|
|
|
- |
|
|
|
16,000 |
|
|
|
- |
|
|
|
- |
|
|
|
16,000 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Fair value of vested options
|
|
|
- |
|
|
|
- |
|
|
|
- |
|
|
|
- |
|
|
|
- |
|
|
|
- |
|
|
|
5,230,000 |
|
|
|
- |
|
|
|
- |
|
|
|
5,230,000 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Fair value of common stock issued as a financing cost
|
|
|
- |
|
|
|
- |
|
|
|
- |
|
|
|
- |
|
|
|
16,931,437 |
|
|
|
1,000 |
|
|
|
3,238,000 |
|
|
|
- |
|
|
|
- |
|
|
|
3,239,000 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Common stock issued upon cashless exercise of options
|
|
|
- |
|
|
|
- |
|
|
|
- |
|
|
|
- |
|
|
|
17,208,335 |
|
|
|
2,000 |
|
|
|
(2,000 |
) |
|
|
- |
|
|
|
- |
|
|
|
- |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Common stock issued upon conversion of notes and accrued
interest
|
|
|
- |
|
|
|
- |
|
|
|
- |
|
|
|
- |
|
|
|
16,168,589 |
|
|
|
2,000 |
|
|
|
1,033,000 |
|
|
|
- |
|
|
|
- |
|
|
|
1,035,000 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Common stock issued upon conversion of debt settlement
|
|
|
- |
|
|
|
- |
|
|
|
- |
|
|
|
- |
|
|
|
460,829 |
|
|
|
- |
|
|
|
88,000 |
|
|
|
- |
|
|
|
- |
|
|
|
88,000 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Net loss
|
|
|
- |
|
|
|
- |
|
|
|
- |
|
|
|
- |
|
|
|
- |
|
|
|
- |
|
|
|
- |
|
|
|
(9,939,000 |
) |
|
|
(7,000 |
) |
|
|
(9,946,000 |
) |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Balance at March 31, 2021 (Unaudited)
|
|
|
3 |
|
|
$ |
987,000 |
|
|
|
36,667 |
|
|
$ |
4,000 |
|
|
|
807,277,505 |
|
|
$ |
81,000 |
|
|
$ |
50,862,000 |
|
|
$ |
(64,335,000 |
) |
|
$ |
(830,000 |
) |
|
$ |
(13,231,000 |
) |
See accompanying notes to the condensed consolidated financial
statements.
STRIKEFORCE TECHNOLOGIES,
INC.
CONDENSED CONSOLIDATED STATEMENTS OF CASH
FLOWS
|
|
For the Three Months
|
|
|
For the Three Months
|
|
|
|
Ended
|
|
|
Ended
|
|
|
|
March 31,
2022
|
|
|
March 31,
2021
|
|
|
|
(Unaudited)
|
|
|
(Unaudited)
|
|
Cash flows from operating activities:
|
|
|
|
|
|
|
Net loss
|
|
$ |
(2,867,000 |
) |
|
$ |
(9,946,000 |
) |
Adjustments to reconcile net loss to net cash used in operating
activities:
|
|
|
|
|
|
|
|
|
Depreciation and amortization
|
|
|
- |
|
|
|
1,000 |
|
Amortization of discount
|
|
|
- |
|
|
|
23,000 |
|
Amortization of right-of-use asset
|
|
|
13,000 |
|
|
|
12,000 |
|
Fair value of common stock issued for services
|
|
|
6,000 |
|
|
|
16,000 |
|
Fair value of vested options
|
|
|
1,636,000 |
|
|
|
5,230,000 |
|
Fair value of common stock issued for financing services
|
|
|
- |
|
|
|
3,239,000 |
|
Change in fair value of derivative liabilities
|
|
|
- |
|
|
|
219,000 |
|
Loss on extinguishment of debt, net
|
|
|
- |
|
|
|
607,000 |
|
Changes in operating assets and liabilities:
|
|
|
|
|
|
|
|
|
Accounts receivable
|
|
|
10,000 |
|
|
|
3,000 |
|
Prepaid expenses
|
|
|
11,000 |
|
|
|
(2,000 |
) |
Accounts payable and accrued expenses
|
|
|
46,000 |
|
|
|
(8,000 |
) |
Accrued interest
|
|
|
99,000 |
|
|
|
34,000 |
|
Operating lease liability
|
|
|
(14,000 |
) |
|
|
(13,000 |
) |
Net cash used in operating activities
|
|
|
(1,060,000 |
) |
|
|
(585,000 |
) |
|
|
|
|
|
|
|
|
|
Cash flows from investing activities:
|
|
|
|
|
|
|
|
|
Purchases of property and equipment
|
|
|
(24,000 |
) |
|
|
- |
|
Net cash used in investing activities
|
|
|
(24,000 |
) |
|
|
- |
|
|
|
|
|
|
|
|
|
|
Cash flows from financing activities:
|
|
|
|
|
|
|
|
|
Proceeds from sale of common stock
|
|
|
- |
|
|
|
1,449,000 |
|
Proceeds from notes payable
|
|
|
- |
|
|
|
177,000 |
|
Repayment of convertible note payable
|
|
|
(20,000 |
) |
|
|
- |
|
Repayment of notes payable
|
|
|
(6,000 |
) |
|
|
(97,000 |
) |
Repayment of convertible notes payable-related parties
|
|
|
- |
|
|
|
(30,000 |
) |
Repayment of notes payable-related parties
|
|
|
- |
|
|
|
(260,000 |
) |
Net cash provided by (used in) financing
activities
|
|
|
(26,000 |
) |
|
|
1,239,000 |
|
|
|
|
|
|
|
|
|
|
Net increase (decrease) in cash
|
|
|
(1,110,000 |
) |
|
|
654,000 |
|
|
|
|
|
|
|
|
|
|
Cash at beginning of the period
|
|
|
2,084,000 |
|
|
|
162,000 |
|
|
|
|
|
|
|
|
|
|
Cash at end of the period
|
|
$ |
974,000 |
|
|
$ |
816,000 |
|
|
|
|
|
|
|
|
|
|
Supplemental disclosure of cash flow
information:
|
|
|
|
|
|
|
|
|
Interest paid
|
|
$ |
- |
|
|
$ |
76,000 |
|
Income tax paid
|
|
$ |
- |
|
|
$ |
- |
|
|
|
|
|
|
|
|
|
|
Supplemental disclosure of non-cash investing and financing
transactions
|
|
|
|
|
|
|
|
|
Common stock issued for conversion of notes and accrued
interest
|
|
$ |
- |
|
|
$ |
1,035,000 |
|
Common stock issued upon conversion of debt settlement
|
|
$ |
- |
|
|
$ |
88,000 |
|
See accompanying notes to the condensed consolidated financial
statements.
StrikeForce Technologies, Inc.
Notes to the Condensed Consolidated Financial Statements
Three months ended March 31, 2022 and 2021
Note 1 - Organization and Summary of
Significant Accounting Policies
StrikeForce Technologies, Inc. (the “Company”) is a software
development and services company that offers a suite of integrated
computer network security products using proprietary technology.
The Company’s operations are based in Edison, New Jersey.
Basis of presentation
and principles of consolidation
The accompanying unaudited condensed consolidated financial
statements have been prepared in accordance with accounting
principles generally accepted in the United States of America
(“U.S. GAAP”) for interim financial information and with the rules
and regulations of the United States Securities and Exchange
Commission (the “SEC”) to Form 10-Q and Article 8 of Regulation
S-X. Accordingly, they do not include all of the information and
footnotes required by U.S. GAAP for complete financial statements.
In the opinion of management, all adjustments (consisting of normal
recurring accruals) considered necessary for a fair presentation of
the financial position, results of operations and cash flows for
the interim periods have been included. The results of operations
for the three months ended March 31, 2022 are not necessarily
indicative of the results of operations to be expected for the full
fiscal year ending December 31, 2022. These financial statements
should be read in conjunction with the financial statements of the
Company for the year ended December 31, 2021 and notes thereto
contained in the Annual Report on Form 10-K of the Company as filed
with the SEC on April 14, 2022.
The condensed consolidated financial statements include the
accounts of the Company and its subsidiary, BlockSafe Technologies,
Inc. (“BST”). BST is owned 49% by the Company and 31% by three
executive officers of the Company. BST meets the definition of a
variable interest entity (“VIE”) and based on the determination
that the Company is the primary beneficiary of BST. BST’s operating
results, assets and liabilities are consolidated by the Company.
Intercompany balances and transactions have been eliminated in
consolidation.
At March 31, 2022, noncontrolling interests represents 51% of BST
that the Company does not directly own. The Company and BST have a
management agreement pursuant to which BST shall remit a management
fee of $36,000 per month to the Company, and when BST reaches a
milestone of $1,000,000 in financing, an additional management fee
of $5,000,000 shall be owed to the Company, payable monthly over
three years. The management fee is eliminated in consolidation. At
March 31, 2022 and December 31, 2021, the amount of VIE cash on the
accompanying condensed consolidated balance sheets can be used only
to settle obligations of BST, and the amounts of VIE accounts
payable, VIE Notes Payable, VIE Accrued Interest, and VIE Financing
Obligation have no recourse to the general credit of the
Company.
Going
Concern
We have yet to establish any history of profitable operations.
During the three months ended March 31, 2022, the Company incurred
a net loss of $2,867,000 and used cash in operating activities of
$1,060,000, and at March 31, 2022, the Company had a stockholders’
deficit of $12,814,000. In addition, we are in default on notes
payable and convertible notes payable in the aggregate amount of
$2,861,000. These factors raise substantial doubt about our ability
to continue as a going concern within one year after the date the
financial statements are issued. In addition, the Company’s
independent registered public accounting firm, in its report
published on our December 31, 2021 year-end financial statements,
raised substantial doubt about the Company’s ability to continue as
a going concern. The Company’s financial statements do not include
any adjustments that might result from the outcome of this
uncertainty should we be unable to continue as a going concern.
Management estimates that the current funds on hand will be
sufficient to continue operations through the next six months.
Our ability to continue as a going concern is dependent upon our
ability to continue to implement our business plan. Currently,
management is attempting to increase revenues by selling through a
channel of distributors, value added resellers, strategic partners
and original equipment manufacturers. While we believe in the
viability of its strategy to increase revenues, there can be no
assurances to that effect. Our ability to continue as a going
concern is dependent upon our ability to increase our customer base
and realize increased revenues. No assurance can be given that any
future financing, if needed, will be available or, if available,
that it will be on terms that are satisfactory to us. Even if we
are able to obtain additional financing, if needed, it may contain
undue restrictions on our operations, in the case of debt
financing, or cause substantial dilution for our stockholders, in
the case of equity financing.
COVID-19
In March 2020, the World Health Organization declared coronavirus
COVID-19 a global pandemic. This contagious disease outbreak, which
has continued to spread, has adversely affected workforces,
customers, economies, and financial markets globally. It has also
disrupted the normal operations of many businesses. This outbreak
could decrease spending, adversely affect demand for the Company’s
products, and harm the Company’s business and results of
operations.
During the three months ended March 31, 2022 and the year ended
December 31, 2021, the Company believes the COVID-19 pandemic did
impact its operating results. For the three months ended March 31,
2022 and the year ended December 31, 2021, sales to customers
decreased by 30% and 7%, respectively, as compared to the prior
year. However, the Company has not observed any impairments of its
assets or a significant change in the fair value of its assets due
to the COVID-19 pandemic. At this time, it is not possible for the
Company to predict the duration or magnitude of the adverse results
of the outbreak and its effects on the Company’s business or
results of operations, financial condition, or liquidity.
The Company has been following the recommendations of health
authorities to minimize exposure risk for its team members during
the pandemic, including the temporary closure of its corporate
office and having team members work remotely. During the second
quarter of 2021, the Company reopened its corporate office while
continuing to adhere to the guidelines issued by health
authorities. Many customers and vendors have transitioned to
electronic submission of invoices and payments.
Use of
Estimates
The preparation of financial statements in conformity with
generally accepted accounting principles requires management to
make estimates and assumptions that affect the reported amounts of
assets and liabilities and disclosure of contingent assets and
liabilities at the date of the financial statements and the
reported amounts of revenues and expenses during the reporting
period. Significant estimates include those related to accounting
for financing obligations, assumptions used in valuing stock
instruments issued for services, assumptions used in valuing
derivative liabilities, the valuation allowance for deferred tax
assets, and the accrual of potential liabilities. Actual results
could differ from those estimates.
Revenue
Recognition
The Company follows the guidance of Accounting Standards
Codification (ASC) 606, Revenue from Contracts with
Customers. ASC 606 creates a five-step model that requires
entities to exercise judgment when considering the terms of
contracts, which includes (1) identifying the contracts or
agreements with a customer, (2) identifying our performance
obligations in the contract or agreement, (3) determining the
transaction price, (4) allocating the transaction price to the
separate performance obligations, and (5) recognizing revenue as
each performance obligation is satisfied. The Company only applies
the five-step model to contracts when it is probable that the
Company will collect the consideration it is entitled to in
exchange for the services it transfers to its clients.
The Company’s revenue consists of revenue from sales and support of
our software products. Revenue primarily consists of sales of
software licenses of our ProtectID®, GuardedID®, MobileTrust® and
SafeVchat™ products. The Company recognizes subscription revenue
over a one-month period based on a typical monthly renewal cycle in
accordance with its customer agreement terms. For service
contracts, the Company’s performance obligations are satisfied, and
the related revenue is recognized, as services are rendered.
The Company offers no discounts, rebates, rights of return, or
other allowances to clients which would result in the establishment
of reserves against service revenue. Additionally, to date, the
Company has not incurred incremental costs in obtaining customer
contracts.
Cost of revenue includes direct costs and fees related to the sale
of our products.
The following tables present our revenue disaggregated by major
product and service lines:
|
|
Three months ended
|
|
|
|
March 31,
2022
|
|
|
March 31,
2021
|
|
Software
|
|
$ |
32,000 |
|
|
$ |
45,000 |
|
Service
|
|
|
- |
|
|
|
1,000 |
|
Total revenue
|
|
$ |
32,000 |
|
|
$ |
46,000 |
|
Fair Value of Financial
Instruments
The Company follows the authoritative guidance issued by the
Financial Accounting Standards Board (“FASB”) for fair value
measurements. Fair value is defined as the price that would be
received to sell an asset or paid to transfer a liability in the
principal or most advantageous market for the asset or liability in
an orderly transaction between market participants at the
measurement date. A fair value hierarchy was established, which
prioritizes the inputs used in measuring fair value into three
broad levels as follows:
Level 1—Quoted prices in active markets for identical assets
or liabilities.
Level 2—Inputs, other than the quoted prices in active
markets, that are observable either directly or indirectly.
Level 3—Unobservable inputs based on the Company’s
assumptions.
The Company is required to use of observable market data if such
data is available without undue cost and effort.
The Company believes the carrying amounts reported in the balance
sheet for accounts receivable, accounts payable, accrued expenses,
convertible notes, and notes payables approximate fair values
because of the short-term nature of these financial
instruments.
Derivative Financial
Instruments
The Company evaluates its financial instruments to determine if
such instruments are derivatives or contain features that qualify
as embedded derivatives. For derivative financial instruments that
are accounted for as liabilities, the derivative instrument is
initially recorded at its fair value and is then re-valued at each
reporting date, with changes in the fair value reported in the
statements of operations. The Company evaluates embedded conversion
features within its convertible debt to determine whether the
embedded conversion features should be bifurcated from the host
instrument and accounted for as a derivative. The fair value of the
embedded derivatives are determined using the trinomial/binomial
valuation method at inception and on subsequent valuation dates.
The classification of derivative instruments, including whether
such instruments should be recorded as liabilities or as equity, is
evaluated at the end of each reporting period. All outstanding
derivative financial instruments were extinguished during fiscal
year 2021.
Stock-Based
Compensation
The Company periodically issues stock options, warrants, and shares
of common stock as share-based compensation to employees and
non-employees in non-capital raising transactions for services and
for financing costs. The Company accounts for such grants issued
and vesting based on FASB ASC 718, Compensation – Stock
Compensation (Topic 718) whereby the value of the award is
measured on the date of grant and recognized as compensation
expense on the straight-line basis over the vesting period. The
Company recognizes the fair value of stock-based compensation
within its Statements of Operations with classification depending
on the nature of the services rendered.
The fair value of the Company’s stock options and warrants are
estimated using the Black-Scholes-Merton option pricing model,
which uses certain assumptions related to risk-free interest rates,
expected volatility, expected life of the stock options or
restricted stock, and future dividends. Compensation expense is
recorded based upon the value derived from the Black-Scholes-Merton
option pricing model and based on actual experience. The
assumptions used in the Black-Scholes-Merton Option Pricing model
could materially affect compensation expense recorded in future
periods.
Loss per
Share
Basic loss per share is computed by dividing net loss available to
common stockholders by the weighted average number of common shares
outstanding during the period. Diluted loss per share is computed
by dividing net loss applicable to common stockholders by the
weighted average number of common shares outstanding, plus the
number of additional common shares that would have been outstanding
if all dilutive potential common shares had been issued using the
treasury stock method. Diluted loss per share excludes all
potential common shares if their effect is anti-dilutive. The
following potentially dilutive shares were excluded from the shares
used to calculate diluted earnings per share as their inclusion
would be anti-dilutive:
|
|
Three months ended
|
|
|
|
March 31, 2022
|
|
|
March 31, 2021
|
|
Options to purchase common stock
|
|
|
83,133,001 |
|
|
|
40,633,001 |
|
Warrants to purchase common stock
|
|
|
68,981,234 |
|
|
|
27,355,475 |
|
Convertible notes
|
|
|
21 |
|
|
|
21 |
|
Convertible Series B Preferred stock
|
|
|
1,284,394 |
|
|
|
492,455 |
|
Total
|
|
|
153,398,650 |
|
|
|
68,480,952 |
|
Concentrations
For the three months ended March 31, 2022, sales to four customers
comprised 38%, 26%, 11% and 10% of revenues. For the three months
ended March 31, 2021, sales to two customers comprised 72% and 15%
of revenues. At March 31, 2022, two customers comprised 59% and 18%
of accounts receivable.
The Company maintains the majority of its cash balances with one
financial institution, in the form of demand deposits. At March 31,
2022, the Company had cash deposits that exceeded the federally
insured limit of $250,000 per account. The Company believes that no
significant concentration of credit risk exists with respect to its
cash balances because of its assessment of the creditworthiness and
financial viability of the financial institution.
Segments
The Company operates in one segment for the development and
distribution of our software products. In accordance with the
“Segment Reporting” Topic of the ASC, the Company’s chief operating
decision maker has been identified as the Chief Executive Officer
and President, who reviews operating results to make decisions
about allocating resources and assessing performance for the entire
Company. Existing guidance, which is based on a management approach
to segment reporting, establishes requirements to report selected
segment information quarterly and to report annually entity-wide
disclosures about products and services, major customers, and the
countries in which the entity holds material assets and reports
revenue. All material operating units qualify for aggregation under
“Segment Reporting” due to their similar customer base, single
sales team, marketing department, customer service department,
operations department, finance and accounting department to support
its operations and similarities in: economic characteristics;
nature of products and services; and procurement, manufacturing and
distribution processes. Since the Company operates in one segment,
all financial information required by “Segment Reporting” can be
found in the accompanying financial statements.
Recent Accounting
Pronouncements
In June 2016, the FASB issued ASU No. 2016-13, Credit
Losses - Measurement of Credit Losses on Financial Instruments
(“ASC 326”). The standard significantly changes how
entities will measure credit losses for most financial assets,
including accounts and notes receivables. The standard will replace
today’s “incurred loss” approach with an “expected loss” model,
under which companies will recognize allowances based on expected
rather than incurred losses. Entities will apply the standard’s
provisions as a cumulative-effect adjustment to retained earnings
as of the beginning of the first reporting period in which the
guidance is effective. As a small business filer, ASU 2020-06 will
be effective January 1, 2024, for the Company and the provisions of
this update can be adopted using either the modified retrospective
method or a fully retrospective method. Management is currently
assessing the impact of adopting this standard on the Company’s
financial statements and related disclosures.
Other recent accounting pronouncements issued by the FASB,
including its Emerging Issues Task Force, the American Institute of
Certified Public Accountants, and the Securities and Exchange
Commission did not or are not believed by management to have a
material impact on the Company’s present or future consolidated
financial statements.
Note 2 - Convertible Notes Payable
Convertible notes payable consisted of the following:
|
|
March 31,
2022
|
|
|
December 31,
2021
|
|
Secured
|
|
|
|
|
|
|
(a) Convertible notes due to AL-Bank
|
|
$ |
483,000 |
|
|
$ |
503,000 |
|
|
|
|
|
|
|
|
|
|
Unsecured
|
|
|
|
|
|
|
|
|
(b) Convertible notes with fixed conversion features, in
default
|
|
|
895,000 |
|
|
|
895,000 |
|
Total Convertible notes
|
|
$ |
1,378,000 |
|
|
$ |
1,398,000 |
|
|
(a)
|
During fiscal 2005, the Company issued notes payable to DART/Citco
Global in the aggregate of $543,000. The notes bear interest at an
average rate of 7.5% per annum and matured in December 2010. The
aggregate notes are convertible by the note holder into
approximately less than one share of the Company’s common stock
based on a fixed conversion price adjusted for applicable reverse
stock splits that occurred in the prior years. In fiscal 2009, the
note holders agreed to the forbearance of any interest on the notes
payable to DART/Citco Global. In August 2021, the notes were
assigned to Aktieselskabet Arbejdernes Landsbank (“AL-Bank”), a
financing institution based in Denmark. In September 2021, the
Company executed a repayment agreement with AL-Bank whereby the
Company shall make monthly payments of $10,000 to AL-Bank, starting
in October 2021 and ending in January 2025, for a total of
$400,000. Once the payments are made in full in accordance with the
repayment agreement, the remaining balance of $143,000 shall be
forgiven and will be accounted at that time. At December 30, 2021,
the outstanding balance of convertible notes payable amounted to
$503,000.
|
|
|
|
|
|
During the three months ended March 31, 2022, the Company made
principal payments of $20,000.
|
|
|
|
|
|
At
March 31, 2022, the outstanding balance of the secured convertible
notes payable amounted to $483,000. The convertible notes payable,
including accrued interest are convertible to approximately two
shares of the Company’s common stock.
|
|
|
|
|
(b)
|
During fiscals 2005 through 2007, the Company issued notes payable
in the aggregate of $895,000. The notes are unsecured, bear
interest at a rate starting at 8% up to 18% per annum, were due on
various dates from March 2008 to March 2015, and are currently in
default. The aggregate notes are convertible by the note holders
into approximately less than one share of the Company’s common
stock based on fixed conversion prices adjusted for applicable
reverse stock splits that occurred in prior years.
|
At March 31, 2022 and December 31, 2021, the outstanding balance of
unsecured convertible notes payable amounted to $895,000,
respectively and deemed in default. The convertible
notes payable, including accrued interest are convertible to
approximately thirteen shares of the Company’s common stock.
Note 3 - Convertible Notes Payable – Related
Parties
In prior years, the Company issued unsecured convertible notes to
its Chief Executive Officer (CEO) in exchange for cash and/or
services rendered. The notes have a compounded interest rate of 8%
per annum and will mature on December 31, 2022, as amended. The
aggregate notes are convertible by the note holders into
approximately less than one share of the Company’s common stock at
fixed conversion prices adjusted for applicable reverse stock
splits that occurred in prior years. As of March 31, 2022 and
December 31, 2021, the outstanding balance of the notes payable
amounted to $268,000. As of March 31, 2022, the convertible notes
payable, including accrued interest are convertible to
approximately six shares of the Company’s common stock.
Note 4 - Notes Payable
Notes payable consisted of the following:
|
|
March 31,
2022
|
|
|
December 31, 2021
|
|
Unsecured notes
|
|
|
|
|
|
|
(a) Notes payable- $1,639,000 - in default
|
|
$ |
1,639,000 |
|
|
$ |
1,639,000 |
|
(b) Notes payable issued by BST - in default
|
|
|
310,000 |
|
|
|
310,000 |
|
(c) Note payable-EID loan
|
|
|
150,000 |
|
|
|
150,000 |
|
|
|
|
|
|
|
|
|
|
Secured notes
payable
|
|
|
|
|
|
|
|
|
(d) Notes payable - in default
|
|
|
16,000 |
|
|
|
23,000 |
|
Total notes payable principal outstanding
|
|
|
2,115,000 |
|
|
|
2,122,000 |
|
Less current portion of notes payable, net of discount
|
|
|
(1,965,000 |
) |
|
|
(1,972,000 |
) |
Long term notes payable
|
|
$ |
150,000 |
|
|
$ |
150,000 |
|
|
(a)
|
In
previous years, the Company issued notes payable in exchange for
cash. The notes are unsecured, bear interest at a rate of 8%
through 14% per annum and matured starting in fiscal 2011 up to
November 2021. At March 31, 2022 and December 31, 2021, the
outstanding balance of the notes payable was $1,639,000,
respectively, and are deemed in default
|
|
|
|
|
(b)
|
In
fiscal 2018, the Company’s consolidated subsidiary BlockSafe,
issued promissory notes in exchange for cash. The notes are
unsecured, bearing interest at a rate of 8% per annum, and matured
in September 2019. At March 31, 2022 and December 31, 2021, the
outstanding balance of the notes payable amounted to $310,000,
respectively, and are deemed in default.
|
|
(c)
|
On
May 15, 2020, the Company received a $150,000 loan (the “EID Loan”)
from the Small Business Administration (SBA) under the SBA’s
Economic Injury Disaster Loan program. The EID Loan has a
thirty-year term and bears interest at a rate of 3.75% per annum.
Monthly principal and interest payments of $250 per month are
deferred for twenty-four months and will commence in June 2022. The
EID Loan may be prepaid at any time prior to maturity with no
prepayment penalties. The proceeds from the EID Loan must be used
for working capital. The EID Loan contains customary events of
default and other provisions customary for a loan of this type.
|
|
|
|
|
|
Outstanding balance of the note payable as of March 31, 2022 and
December 31, 2021 amounted to $150,000, respectively. The Company
was in compliance with the terms of the EID loan as of March 31,
2022.
|
|
|
|
|
(d)
|
In
fiscal 2019 and 2020, the Company issued notes payable aggregating
$468,000. The notes bear interest at a rate starting from 8% to
148% per annum, each agreement secured by substantially all of the
assets of the Company, maturing between March 2020 and July 2021.
The Company also made principal payments of $319,000, and one
secured note of $21,000 was extinguished as part of a debt
settlement obligation transaction. At December 31, 2021, the
outstanding balance of the secured note agreements was $23,000.
|
|
|
|
|
|
During the three months ended March 31, 2022, the Company made
principal payments of $7,000.
|
|
|
|
|
|
At
March 31, 2022, the outstanding balance of the secured notes
payable was $16,000 and is deemed in default. The Company and the
note holder are in negotiations to extend the due date of the
note.
|
Note 5 - Notes Payable – Related Party
Notes payable-related party notes represent unsecured notes payable
to the Company’s Chief Executive Officer (CEO) ranging in interest
rates of 0% per annum to 10% per annum and will mature on December
31, 2022, as amended. The outstanding balance of these notes
payable at March 31, 2022 and December 31, 2021 amounted to
$693,000, respectively.
Note 6 – Financing Obligation
The Company is in the process of developing Coins or Tokens which
are an envisioned virtual currency. In fiscal 2018, the Company’s
consolidated subsidiary BlockSafe (BST), issued promissory notes to
unrelated parties aggregating $776,000. As part of issuance, the
Company agreed to pay a financing obligation to the note holders
equal to the note principal in tokens, as defined, to be issued by
BlockSafe. In addition, the Company also agreed to issue tokens to
an unrelated party in exchange for cash of $50,000.
During the year ended December 31, 2019, BlockSafe agreed to issue
tokens to unrelated parties in exchange for cash of $122,000. In
addition, certain note holders of promissory notes issued by
BlockSafe agreed to exchange $315,000 of outstanding principal and
accrued interest into the financing obligation to be paid by tokens
to be issued by BlockSafe.
At March 31, 2022 and December 31, 2021, the outstanding balance of
financing obligations amounted to $1,263,000, respectively, to be
paid in tokens, as defined. At March 31, 2022 and through the date
of filing, BST has not developed or issued any tokens and there is
no assurance as to whether, or at what amount, or on what terms,
tokens will be available to be issued, if ever. At March 31, 2022,
as the tokens do not exist, and any amounts received for tokens are
not considered equity or revenue, management determined that 100%
of the obligation of $1,263,000 is a liability to be settled by
BST, through the issuance of tokens, or through other means if
tokens are never issued.
Note 7 – Contingent Payment Obligation
On September 6, 2017, the Company entered into a litigation funding
agreement with Therium Inc. (subsequently Therium Luxembourg) and
VGL Capital, LLC (collectively the “Funders”). Under the agreement,
the Company received $1,500,000 from the Funders to allow the
Company to pursue patent enforcement actions against infringements
of its patents. In exchange, the Funders are entitled to receive,
after the payment of legal fees, the first $1,500,000 from the
gross proceeds of any claims awarded, 10% of any additional claim
proceeds until the Funders have received an additional $7,500,000,
and 2.5% of any claim proceeds thereafter. The Funders shall be
paid only in the event that the Company achieves recoveries of
claim proceeds.
At March 31, 2022 and December 31, 2021, the Company has reflected
the $1,500,000 received from the Funders as a contingent payment
obligation to be paid only if claim proceeds are recovered.
Note 8 - Operating Lease
In January 2019, the Company entered into a noncancelable operating
lease for its office headquarters office requiring payments of
approximately $4,000 per month, payments increasing 3% each year,
and ending on January 31, 2024. We determine if an arrangement is a
lease at inception. Lease assets are presented as operating lease
right-of-use assets and the related liabilities are presented as
lease liabilities in our consolidated balance sheets pursuant to
ASC 842, Leases.
Operating lease right-of-use (“ROU”) assets and liabilities are
recognized at commencement date based on the present value of lease
payments over the lease term. ROU assets represent our right to use
an underlying asset for the lease term and lease liabilities
represent the Company’s obligation to make lease payments arising
from the lease. Generally, the implicit rate of interest in
arrangements is not readily determinable and the Company utilizes
its incremental borrowing rate in determining the present value of
lease payments. The operating lease ROU asset includes any lease
payments made and excludes lease incentives.
The components of lease expense and supplemental cash flow
information related to leases for the period are as follows:
|
|
Three months ended
March 31,
2022
|
|
|
Three months ended
March 31,
2021
|
|
Lease Cost
|
|
|
|
|
|
|
Operating lease cost (included in general and administration in the
Company’s statement of operations)
|
|
$ |
14,000 |
|
|
$ |
14,000 |
|
|
|
|
|
|
|
|
|
|
Other
Information
|
|
|
|
|
|
|
|
|
Cash paid for amounts included in the measurement of lease
liabilities for the three months ended March 31, 2022 and 2021
|
|
$ |
14,000 |
|
|
$ |
14,000 |
|
Weighted average remaining lease term – operating leases (in
years)
|
|
|
1.8 |
|
|
|
2.8 |
|
Average discount rate – operating leases
|
|
|
10.0 |
% |
|
|
10.0 |
% |
The supplemental balance sheet information related to leases for
the period is as follows:
|
|
At March 31, 2022
|
|
Operating leases
|
|
|
|
Long-term right-of-use assets
|
|
$ |
94,000 |
|
|
|
|
|
|
Short-term operating lease liabilities
|
|
$ |
55,000 |
|
Long-term operating lease liabilities
|
|
|
43,000 |
|
Total operating lease liabilities
|
|
$ |
98,000 |
|
Maturities of the Company’s lease liabilities are as follows:
Year Ending
|
|
Operating Leases
|
|
2022 (9 months)
|
|
|
43,000 |
|
2023
|
|
|
59,000 |
|
2024
|
|
|
5,000 |
|
Total lease payments
|
|
|
107,000 |
|
Less: Imputed interest/present value discount
|
|
|
(9,000 |
) |
Present value of lease liabilities
|
|
$ |
98,000 |
|
Lease expenses were $14,000 and $14,000 during the three months
ended March 31, 2022 and 2021, respectively.
Note 9 – Stockholders’ Deficit
Common
Stock
During the three months ended March 31, 2022, the Company issued an
aggregate of 134,853 shares of its common stock for consulting
services, with a fair value of $6,000.
Warrants
The table below summarizes the Company’s warrant activities for the
three months ended March 31, 2022:
|
|
Number of
Warrant Shares
|
|
|
Exercise Price Range
Per Share
|
|
|
Weighted Average Exercise Price
|
|
|
|
|
|
|
|
|
|
|
|
Balance, January 1, 2022
|
|
|
68,981,234 |
|
|
0.0045-2.90
|
|
|
$ |
0.042647 |
|
Granted
|
|
|
- |
|
|
|
- |
|
|
|
- |
|
Canceled/Expired
|
|
|
- |
|
|
|
- |
|
|
|
- |
|
Exercised
|
|
|
- |
|
|
|
- |
|
|
|
- |
|
Balance, March 31, 2022
|
|
|
68,981,234 |
|
|
$ |
0.0045-2.90
|
|
|
$ |
0.042647 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Balance outstanding and exercisable, March 31, 2022
|
|
|
68,981,234 |
|
|
$ |
0.0045-2.90
|
|
|
$ |
0.042647 |
|
At
March 31, 2022, the intrinsic value of the warrants amounted to
$464,000.
The following table summarizes information concerning outstanding
and exercisable warrants as of March 31, 2022:
|
|
|
Warrants Outstanding and Exercisable
|
|
Range of Exercise Prices
|
|
|
Number Outstanding
|
|
|
Average Remaining
Contractual Life
(in years)
|
|
|
Weighted Average
Exercise Price
|
|
|
|
|
|
|
|
|
|
|
|
|
$ |
0.0045
|
|
|
|
13,349,242 |
|
|
|
4.00 |
|
|
$ |
0.0045 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
$ |
0.085
|
|
|
|
588,235 |
|
|
|
4.00 |
|
|
$ |
0.085 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
$ |
0.05
|
|
|
|
55,000,000 |
|
|
|
5.00 |
|
|
$ |
0.05 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
$ |
0.75
|
|
|
|
26,515 |
|
|
|
3.00 |
|
|
$ |
0.75 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
$ |
2.90
|
|
|
|
17,241 |
|
|
|
3.00 |
|
|
$ |
2.90 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
$ |
0.0045 - $2.90
|
|
|
|
68,981,234 |
|
|
|
4.00 |
|
|
$ |
0.042647 |
|
Note 10 – Stock Options
The table below summarizes the Company’s stock option activities
for the three months ended March 31, 2022:
|
|
Number of
Options Shares
|
|
|
Exercise Price Range
Per Share
|
|
|
Weighted Average Exercise Price
|
|
Balance, January 1, 2022
|
|
|
83,133,001 |
|
|
0.005-
1,121,250,000
|
|
|
$ |
0.0274 |
|
Granted
|
|
|
- |
|
|
|
- |
|
|
|
- |
|
Exercised
|
|
|
- |
|
|
|
- |
|
|
|
- |
|
Expired
|
|
|
- |
|
|
|
- |
|
|
|
- |
|
Balance outstanding, March 31, 2022
|
|
|
83,133,001 |
|
|
$ |
0.005-
1,121,250,000
|
|
|
$ |
0.0274 |
|
Balance exercisable, March 31, 2022
|
|
|
53,433,547 |
|
|
$ |
0.005-
1,121,250,000
|
|
|
$ |
0.0274 |
|
At March 31, 2022, the intrinsic value of outstanding options was
$717,000.
During the period ended March 31, 2022, the Company recognized
stock compensation expense of $1,636,000 to account the fair value
of stock options that vested. As of March 31, 2022, fair value of
unvested stock options amounted to $1.3 million and will be
recognized as stock compensation expense in future periods as it
vests.
The following table summarizes information concerning the Company’s
stock options as of March 31, 2022:
|
|
|
Options Outstanding
|
|
|
Options Exercisable
|
|
Range of Exercise Prices
|
|
|
Number Outstanding
|
|
|
Average Remaining Contractual Life (in years)
|
|
|
Weighted Average Exercise Price
|
|
|
Number Exercisable
|
|
|
Average Remaining Contractual Life (in years)
|
|
|
Weighted Average Exercise Price
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
$ |
1,121,250,000
|
|
|
|
1 |
|
|
|
2 |
|
|
$ |
1,121,250,000 |
|
|
|
1 |
|
|
|
1 |
|
|
$ |
1,121,250,000 |
|
$ |
2.85
|
|
|
|
126,000 |
|
|
|
7 |
|
|
|
2.85 |
|
|
|
126,000 |
|
|
|
6 |
|
|
|
2.85 |
|
$ |
3.125
|
|
|
|
392,000 |
|
|
|
6 |
|
|
|
3.125 |
|
|
|
392,000 |
|
|
|
5 |
|
|
|
3.125 |
|
$ |
2.05
|
|
|
|
115,000 |
|
|
|
9 |
|
|
|
2.05 |
|
|
|
115,000 |
|
|
|
8 |
|
|
|
2.05 |
|
$ |
0.0375
|
|
|
|
65,000,000 |
|
|
|
10 |
|
|
|
0.0375 |
|
|
|
36,748,634 |
|
|
|
10 |
|
|
|
0.0375 |
|
$ |
0.005
|
|
|
|
17,500,000 |
|
|
|
10 |
|
|
|
0.005 |
|
|
|
16,051,912 |
|
|
|
10 |
|
|
|
0.005 |
|
$ |
0.005 – 1,121,250,000
|
|
|
|
83,133,001 |
|
|
|
6.8 |
|
|
$ |
0.03704 |
|
|
|
53,433,547 |
|
|
|
6.8 |
|
|
$ |
0.0274 |
|
Note 11 – Subsequent Events
Subsequent to March 31, 2022, the Company issued 96,083 shares of
common stock for services with a fair value of $4,000.
In May 2022, the Company amended the exercise price of 50 million
shares of stock warrants granted in September 2021 from $0.05 per
share to $0.02 per share. As a result, these warrant holders
exercised their warrants and the Company issued 50 million shares
of common stock for cash proceeds of $1,000,000. As an
inducement to these warrant holders to exercise their warrants, the
Company granted them stock warrants to purchase 50 million shares
of common stock. The warrants are exercisable at $0.05 per
share and will expire in 5 years. The Company is in the process of
determining the appropriate accounting for these transactions.
ITEM 2. MANAGEMENT’S DISCUSSION AND ANALYSIS OF
FINANCIAL CONDITION AND RESULTS OF OPERATIONS
CAUTIONARY STATEMENT REGARDING FORWARD-LOOKING
STATEMENTS
Included in this interim report are “forward-looking” statements,
within the meaning of the Private Securities Litigation Reform Act
of 1995 (“PSLRA”) as well as historical information. Some of our
statements under “Business”, “Properties”, “Legal Proceedings”,
“Management’s Discussion and Analysis of Financial Condition and
Results of Operations”,” the Notes to Condensed Consolidated
Financial Statements” and elsewhere in this report constitute
“forward-looking statements” within the meaning of Section 27A of
the Securities Act of 1933 and Section 21E of the Securities
Exchange Act of 1934. Although we believe that the expectations
reflected in these forward-looking statements are reasonable, we
cannot assure you that the expectations reflected in these
forward-looking statements will prove to be correct. Our actual
results could differ materially from those anticipated in
forward-looking statements as a result of certain factors,
including matters described in the section titled “Risk Factors.”
Forward-looking statements include those that use forward-looking
terminology, such as the words “anticipate,” “believe,” “estimate,”
“expect,” “intend,” “may,” “project,” “plan,” “will,” “shall,”
“should,” and similar expressions, including when used in the
negative. Although we believe that the expectations reflected in
these forward-looking statements are reasonable and achievable,
these statements involve risks and uncertainties and we cannot
assure you that actual results will be consistent with these
forward-looking statements. We claim the protection afforded by the
safe harbor for forward-looking statements provided by the
PSLRA.
Such risks include, among others, the following: international,
national and local general economic and market conditions: our
ability to sustain, manage or forecast our growth; material costs
and availability; new product development and introduction;
existing government regulations and changes in, or the failure to
comply with, government regulations; adverse publicity;
competition; the loss of significant customers or suppliers;
fluctuations and difficulty in forecasting operating results;
changes in business strategy or development plans; business
disruptions; the current inflation rate and supply chain
disruptions; the implications and consequences of the COVID-19
pandemic on our business and on our clients’ business and on the
effectiveness and distributions of vaccines and boosters,
domestically and internationally, to limit the impact of COVID-19,
and changes to mask mandate policies and to transitioning from a
pandemic to an endemic; the ability to attract and retain qualified
personnel; the ability to protect technology; and other factors
referenced in this filing.
Consequently, all the forward-looking statements made in this Form
10-Q are qualified by these cautionary statements and there can be
no assurance that the actual results anticipated by management will
be realized or, even if substantially realized, that they will have
the expected consequences to or effects on our business operations.
We undertake no obligation to update or revise these
forward-looking statements, whether to reflect events or
circumstances after the date initially filed or published, to
reflect the occurrence of unanticipated events or otherwise.
Unless otherwise noted, references in this Form 10-Q to
“StrikeForce”, “we”, “us”, “our”, “SFT”, “our company”, and the
“Company” means StrikeForce Technologies, Inc., a Wyoming
corporation.
Background
We are a software development and services company that offers a
suite of integrated computer network security products using
proprietary technology. Our ongoing strategy is developing and
marketing our suite of network security products to the corporate,
financial, healthcare, legal, government, technology, insurance,
e-commerce and consumer sectors. We plan to continue to grow our
business primarily through our expanding sales channel and
internally generated sales, rather than by acquisitions. We hold a
49% interest in BlockSafe Technologies, Inc., and a 100% interest
in Cybersecurity Risk Solutions, LLC.
In March 2020, the World Health Organization declared the spread of
COVID-19 a pandemic. This outbreak continues to spread throughout
the U.S. and around the world. As a result, authorities
continue to implement numerous measures to try to contain the
virus, including restrictions on travel, quarantines,
shelter-in-place orders, business restrictions and complete
shutdowns. We are not considered an “essential business” due to the
industries and customers we serve. As of, and subsequent to, March
31, 2022, we have been following the recommendations of the CDC and
state/local health authorities to minimize exposure risk for our
team members during the pandemic, including the temporary closure
of our corporate office and having our team members work remotely.
During the second quarter of 2021, we reopened our corporate office
while continuing to adhere to the guidelines issued by health
authorities. Many customers and vendors have transitioned to
electronic submission of invoices and payments. The COVID-19
pandemic has resulted in longer response times from potential new
customers and certain existing customers. We cannot anticipate the
effect that the impairments caused by the COVID-19 pandemic will
have on our fiscal 2022 or 2023 results, or the effectiveness and
distributions of vaccines, boosters, and their distribution in 2022
and 2023, changes to mask mandate policies and to transitioning
from a pandemic to an endemic. The pandemic has significantly
impacted the economic conditions both in the United States and
worldwide, with accelerated effects through the date of this
report, as federal, state and local governments react to the public
health crisis, creating significant uncertainties in both the
worldwide and the United States economies. The situation is rapidly
changing, including the onset of the ongoing subsequent waves of
the virus caused by the possibility of various variants over time,
and additional impacts to our business may arise that we are not
aware of currently. We cannot predict whether, when or the manner
in which, the conditions surrounding COVID-19 will change
including the timing of lifting any restrictions or office closure
requirements. We will continue to evaluate the nature and extent of
COVID-19’s impact to our business, consolidated results of
operations, financial condition and liquidity, and our results
presented herein are not necessarily indicative of the results to
be expected for future periods.
During the three months ended March 31, 2022, we believe the
COVID-19 pandemic did impact our operating results as sales to
customers were down 30% as compared from the three months ended
March 31, 2021. However, we have not observed any impairments of
our assets or a significant change in the fair value of our assets
due to the COVID-19 pandemic. At this time, it is not possible for
us to predict the duration or magnitude of the adverse results of
the outbreak and its effects on our business or results of
operations, financial condition, or liquidity.
We have been following the recommendations of health authorities to
minimize exposure risk for our team members, including the
temporary closure of our corporate office and having team members
work remotely. Most customers and vendors have transitioned to
electronic submission of invoices and payments.
Management believes that cyber security is a growing requirement as
the pandemic continues, and that more people are working remotely
as well as using digital forms on a regular basis. Consequently,
the market demand, in our estimation, is increasing. However, our
company is also experiencing the impact of the ongoing pandemic.
Currently our management is not working from our office location
and it impedes our ability to take full advantage of the increasing
market demand. Many of our current clients have experienced a
dramatic slowdown in their business, limiting their ability to have
the resources to pay for our services. We still generate revenues
and we anticipate, but cannot guarantee, we will have the resources
to advance our video conferencing tool, SafeVchat™ and PrivacyLoK™,
that provides authentication and encryption (using our existing
products), for which we believe there will be great interest in the
market. During the three months ended March 31, 2022 and the year
ended December 31, 2021, we earned revenues of $3,000 and $74,000,
respectively, from SafeVchat™ and PrivacyLoK™ and overall revenues
of $32,000 and $193,000, respectively.
Our executive office is located at 1090 King Georges Post Road,
Suite 603, Edison, NJ 08837. Our telephone number is (732)
661-9641. At March 31, 2022, we had 14 employees. Our Company’s
website is www.strikeforcetech.com (we are not including the
information contained in our website as part of, nor should the
information be relied upon or incorporated by reference into, this
report on Form 10-Q).
Results of Operations
FOR THE THREE MONTHS ENDED MARCH 31, 2022 COMPARED TO THE
THREE MONTHS ENDED MARCH 31, 2021
Revenues for the three months ended March 31, 2022 were $32,000
compared to $46,000 for the three months ended March 31, 2021, a
decrease of $14,000 or 30.4%. The decrease in revenues was
primarily due to a decrease in revenues relating to our ProtectID®,
GuardedID® and MobileTrust® products, offset by an increase in
revenues relating to our SafeVchat™ product, despite the
impairments related to the economic consequences of the COVID-19
pandemic. Revenues are derived from software and services.
Cost of revenues for the three months ended March 31, 2022 was
$10,000 compared to $3,000 for the three months ended March 31,
2021, an increase of $7,000 or 233%. The increase in cost of
revenues was primarily due to an increase in the fees related to
our product offerings. Cost of revenues are fees and key fobs
related to our revenues, and as a percentage of total revenues for
the three months ended March 31, 2022 was 31.3% compared to 6.5%
for the three months ended March 31, 2021.
Research and development expenses for the three months ended March
31, 2022 were $154,000 compared to $145,000 for the three months
ended March 31, 2021, an increase of $9,000 or 6.2%. The increase
was primarily due to the overall increase in salaries and benefits
of the personnel conducting research and development. The salaries,
benefits and overhead costs of personnel conducting research and
development of our software products primarily comprises our
research and development expenses.
Compensation, professional fees, and selling, general and
administrative (collectively, “SGA”) expenses for the three months
ended March 31, 2022 were $2,636,000 compared to $5,628,000 for the
three months ended March 31, 2021, a decrease of $2,992,000 or
53.2%. The decrease was due primarily to a decrease in employee
stock-based compensation, offset by an increase in compensation
expenses and professional fees. SG&A expenses consist primarily
of salaries, benefits and overhead costs for executive and
administrative personnel, insurance, fees for professional
services, including consulting, legal, and accounting fees, plus
travel costs and non-cash stock compensation expense for the
issuance of stock options to employees and other general corporate
expenses.
For the three months ended March 31, 2022, other expense was
$99,000 as compared to other expense of $4,216,000 for the three
months ended March 31, 2021, a decrease in other expense of
$4,117,000, or 9.8%. The decrease was primarily due to decreases in
financing expense, interest expense, debt discount amortization,
and the change in the fair value of derivative
liabilities. The Company’s derivative liabilities were
fully extinguished in fiscal 2021.
Our net loss for the three months ended March 31, 2022 was
$2,867,000 compared to $9,946,000 for the three months ended March
31, 2021, a decrease of $7,079,000, or 71.2%. The decrease was
primarily due to decreases in employee stock-based compensation,
financing expense, interest expense, debt discount amortization,
and the change in the fair value of derivative liabilities, offset
by an increase in compensation expenses and professional fees.
Liquidity and Capital Resources
Our total current assets at March 31, 2022 were $990,000, which
included cash of $974,000, as compared with $2,121,000 in total
current assets at December 31, 2021, which included cash of
$2,084,000. Additionally, we had a stockholders’ deficit in the
amount of $12,814,000 at March 31, 2022 compared to a stockholders’
deficit of $11,589,000 at December 31, 2021. We have historically
incurred recurring losses and have financed our operations through
loans, principally from affiliated parties such as our directors,
and from the proceeds of debt and equity financing. We financed our
operations during the three months ended March 31, 2022 primarily
from the cash balance from the year ended December 31, 2021.
Concentrations
For the three months ended March 31, 2022, sales to four customers
comprised 38%, 26%, 11% and 10% of revenues. For the three months
ended March 31, 2021, sales to two customers comprised 72% and 15%
of revenues. At March 31, 2022, two customers comprised 59% and 18%
of accounts receivable.
Going Concern
We have yet to establish any history of profitable operations.
During the three months ended March 31, 2022, the Company incurred
a net loss of $2,867,000 and used cash in operating activities of
$1,060,000, and at March 31, 2022, the Company had a stockholders’
deficit of $12,814,000. In addition, we are in default on notes
payable and convertible notes payable in the aggregate amount of
$2,861,000. These factors raise substantial doubt about our ability
to continue as a going concern within one year after the date the
financial statements are issued. In addition, the Company’s
independent registered public accounting firm, in its report
published on our December 31, 2021 year-end financial statements,
and Note 1 in our unaudited financial statements, raised
substantial doubt about the Company’s ability to continue as a
going concern. The Company’s financial statements do not include
any adjustments that might result from the outcome of this
uncertainty should we be unable to continue as a going concern.
Management estimates that the current funds on hand will be
sufficient to continue operations through the next six months.
Our ability to continue as a going concern is dependent upon our
ability to continue to implement our business plan. Currently,
management is attempting to increase revenues by selling through a
channel of distributors, value added resellers, strategic partners
and original equipment manufacturers. While we believe in the
viability of its strategy to increase revenues, there can be no
assurances to that effect. Our ability to continue as a going
concern is dependent upon our ability to increase our customer base
and realize increased revenues. No assurance can be given that any
future financing, if needed, will be available or, if available,
that it will be on terms that are satisfactory to us. Even if we
are able to obtain additional financing, if needed, it may contain
undue restrictions on our operations, in the case of debt
financing, or cause substantial dilution for our stockholders, in
the case of equity financing.
Cybersecurity Risk Solutions, LLC
On April 15, 2021, StrikeForce formally closed a Member Interest
Purchase Agreement in which StrikeForce acquired the entire Member
Interests of Cybersecurity Risk Solutions, LLC, a New Jersey
limited liability company. In April 2021, we issued 500,000 shares
of common stock with a fair value of $36,000, for the purchase of
Cybersecurity Risk Solutions, LLC. At the date of acquisition,
Cybersecurity Risk Solutions, LLC had nominal assets and
liabilities, no revenues and limited operating history.
Furthermore, the Company also determined that the acquisition did
not meet the requirement of a significant acquisition pursuant to
the regulations of the Securities and Exchange Commission.
Cybersecurity Risk Solutions, LLC is a cybersecurity firm offering
cyber, privacy & data protection services including a personal
cyber risk assessment, the industry’s first cyber health score,
report and custom action plan, as well as ongoing vulnerability
scanning, hack monitoring and dark web intelligence monitoring. For
more information, go to https://SecureCyberID.com (which
website is expressly not included in this filing). Will Lynch, the
prior sole member of Cybersecurity Risk Solutions, LLC was hired by
StrikeForce as the Director of Channel Distribution and not as a
Named Executive Officer. A Director of Channel Distribution
develops, services, and grows relationships with clients. Mr. Lynch
has an annual salary of $100,000 and will also receive 2% net of
all Channel sales. Mr. Lynch reports to our Executive Vice
President and Marketing Director.
Subsequent Events
Subsequent to March 31, 2022, the Company issued 50,000,000 shares
of common stock for the exercise of 50,000,000 common stock
purchase warrants at $0.02 per share for total proceeds of
$1,000,000.
Off-Balance Sheet Arrangements
We do not have any off-balance sheet arrangements that are
reasonably likely to have a current or future effect on our
financial condition, revenues, result of operations, liquidity or
capital expenditures.
Critical Accounting Policies
Use of Estimates
The preparation of financial statements in conformity with
generally accepted accounting principles requires management to
make estimates and assumptions that affect the reported amounts of
assets and liabilities and disclosure of contingent assets and
liabilities at the date of the financial statements and the
reported amounts of revenues and expenses during the reporting
period. Significant estimates include those related to accounting
for financing obligations, assumptions used in valuing stock
instruments issued for services, assumptions used in valuing
derivative liabilities, the valuation allowance for deferred tax
assets, and the accrual of potential liabilities. Actual results
could differ from those estimates.
Revenue Recognition
The Company follows the guidance of Accounting Standards
Codification (ASC) 606, Revenue from Contracts with
Customers. ASC 606 creates a five-step model that requires
entities to exercise judgment when considering the terms of
contracts, which includes (1) identifying the contracts or
agreements with a customer, (2) identifying our performance
obligations in the contract or agreement, (3) determining the
transaction price, (4) allocating the transaction price to the
separate performance obligations, and (5) recognizing revenue as
each performance obligation is satisfied. The Company only applies
the five-step model to contracts when it is probable that the
Company will collect the consideration it is entitled to in
exchange for the services it transfers to its clients.
The Company’s revenue consists of revenue from sales and support of
our software products. Revenue primarily consists of sales of
software licenses and subscriptions of our ProtectID®, GuardedID®,
MobileTrust®, PrivacyLoK™ and SafeVchat™ products. We recognize
revenue from these arrangements ratably over the contractual
service period. For service contracts, the Company’s performance
obligations are satisfied, and the related revenue is recognized,
as services are rendered.
The Company offers no discounts, rebates, rights of return, or
other allowances to clients which would result in the establishment
of reserves against service revenue. Additionally, to date, the
Company has not incurred incremental costs in obtaining a client
contract.
Cost of revenue includes direct costs and fees related to the sale
of our products.
Share-Based Payments
The Company periodically issues stock options, warrants, and shares
of common stock as share-based compensation to employees and
non-employees in non-capital raising transactions for services and
for financing costs. The Company accounts for such grants issued
and vesting based on FASB ASC 718, Compensation – Stock
Compensation (Topic 718) whereby the value of the award is measured
on the date of grant and recognized as compensation expense on the
straight-line basis over the vesting period. The Company recognizes
the fair value of stock-based compensation within its Statements of
Operations with classification depending on the nature of the
services rendered.
Recently Issued Accounting Pronouncements
Refer to Note 1 in the accompanying consolidated financial
statements.
Additional Information
You are advised to read this Form 10-Q in conjunction with other
reports and documents that we file from time to time with the SEC.
In particular, please read our Quarterly Reports on Form 10-Q,
Annual Reports on Form 10-K, and Current Reports on Form 8-K that
we file from time to time. You may obtain copies of these reports
directly from us or from the SEC at the SEC’s Public Reference Room
at 100 F. Street, N.E. Washington, D.C. 20549, and you may obtain
information about obtaining access to the Reference Room by calling
the SEC at 1-800-SEC-0330. In addition, the SEC maintains
information for electronic filers at its website
http://www.sec.gov.
ITEM 3. QUANTITATIVE AND QUALITATIVE DISCLOSURES
ABOUT MARKET RISK
As a smaller reporting company, we are not required to provide the
information required by this Item.
ITEM 4. CONTROLS AND
PROCEDURES
(a) Evaluation of Disclosure Controls and
Procedures.
Regulations under the Securities Exchange Act of 1934 (the
“Exchange Act”) require public companies to maintain “disclosure
controls and procedures,” which are defined as controls and other
procedures that are designed to ensure that information required to
be disclosed by the issuer in the reports that it files or submits
under the Exchange Act is recorded, processed, summarized and
reported, within the time periods specified in the Securities and
Exchange Commission’s rules and forms. Disclosure controls and
procedures include, without limitation, controls and procedures
designed to ensure that information required to be disclosed by an
issuer in the reports that it files or submits under the Exchange
Act is accumulated and communicated to the issuer’s management,
including its principal executive and principal financial officers,
or persons performing similar functions, as appropriate to allow
timely decisions regarding required disclosure.
We carried out an evaluation, with the participation of our
management, including our Chief Executive Officer (“CEO”) and our
Chief Financial Officer (CFO) of the effectiveness our disclosure
controls and procedures (as defined under Rule 13a-15(e) under the
Exchange Act) as of March 31, 2022. Based upon that evaluation, our
CEO and CFO concluded that our disclosure controls and procedures
are not effective at the reasonable assurance level due to the
following material weaknesses:
1. We do not have written documentation of our internal control
policies and procedures. Written documentation of key internal
controls over financial reporting is a requirement of Section 404
of the Sarbanes-Oxley Act which is applicable to us as of and for
the interim period ended March 31, 2022. Management evaluated the
impact of our failure to have written documentation of our internal
controls and procedures on our assessment of our disclosure
controls and procedures and has concluded that the control
deficiency that resulted represented a material weakness.
2. Our board of directors has no independent director or member
with financial expertise which causes ineffective oversight of our
external financial reporting and internal control over financial
reporting.
3. We do not have sufficient segregation of duties within
accounting functions, which is a basic internal control. Due to our
size and nature, segregation of all conflicting duties may not
always be possible and may not be economically feasible. However,
to the extent possible, the initiation of transactions, the custody
of assets and the recording of transactions should be performed by
separate individuals. Management evaluated the impact of our
failure to have segregation of duties on our assessment of our
disclosure controls and procedures and has concluded that the
control deficiency that resulted represented a material
weakness.
To address these material weaknesses, management performed
additional analyses and other procedures to ensure that the
financial statements included herein fairly present, in all
material respects, our financial position, results of operations
and cash flows for the periods presented.
Remediation of Material
Weaknesses
We intend to remediate the material weaknesses in our disclosure
controls and procedures identified above by adding an independent
director or member with financial expertise or hiring a full-time
CFO with SEC reporting experience in the future when working
capital permits and by working with our independent registered
public accounting firm to refine our internal procedures.
(b) Changes in Internal Control over
Financial Reporting
There were no changes in our internal control over financial
reporting, as defined in Rules 13a-15(f) and 15d-15(f) under the
Exchange Act, during our most recently completed fiscal quarter
that have materially affected, or are reasonably likely to
materially affect, our internal control over financial
reporting.
PART II - OTHER
INFORMATION
ITEM 1. LEGAL PROCEEDINGS
None.
ITEM 1A. RISK FACTORS
The risk factors required pursuant to Regulation S-K, Item 503(c)
are not required for smaller reporting companies. Accordingly, the
Company has determined to provide particular risk factors at this
time. The risks and uncertainties described below are not the only
ones facing us. Other events that we do not currently anticipate or
that we currently deem immaterial also may affect our results of
operations and financial condition. If any events described in the
risk factors actually occur, our business, operating results,
prospects and financial condition could be materially harmed. In
connection with the forward-looking statements that appear in our
Annual Report on Form 10-K for the year ended December 31, 2021,
which was filed with the Securities and Exchange Commission on
April 14, 2022, you should also carefully review the cautionary
statement referred to under “Special Note Regarding Forward Looking
Statements.” The forward-looking statements made in this report
relate only to events as of the date on which the statements are
made. We undertake no obligation to update any forward-looking
statement to reflect events or circumstances after the date on
which the statement is made or to reflect the occurrence of
unanticipated events.
COVID-19.
We cannot, at this point, determine the extent to which COVID-19
outbreak will impact business or the economy as both are highly
uncertain and cannot be predicted.
THE OUTBREAK OF THE CORONAVIRUS MAY NEGATIVELY IMPACT
SOURCING AND MANUFACTURING OF THE PRODUCTS THAT WE SELL AS WELL AS
CONSUMER SPENDING, WHICH COULD ADVERSELY AFFECT OUR BUSINESS,
RESULTS OF OPERATIONS AND FINANCIAL CONDITION.
In December 2019, a novel strain of coronavirus was reported to
have surfaced in Wuhan, China, which has and is continuing to
spread throughout China and other parts of the world, including the
United States. On January 30, 2020, the World Health Organization
declared the outbreak of the coronavirus disease (COVID-19) a
“Public Health Emergency of International Concern.” On January 31,
2020, U.S. Health and Human Services Secretary Alex M. Azar II
declared a public health emergency for the United States to aid the
U.S. healthcare community in responding to COVID-19, and on March
11, 2020 the World Health Organization characterized the outbreak
as a “pandemic”. The significant outbreak of COVID-19 has resulted
in a widespread health crisis that could adversely affect the
economies and financial markets worldwide, and could adversely
affect our business, results of operations and financial
condition.
In addition, we applied for funding pursuant to the Small Business
Administration program. The Paycheck Protection Program provided
forgivable funding for payroll and related costs as well as some
non-payroll costs. We applied for funding and we received (on April
17, 2020) funding in the amount of $313,000. In June 2021, the
April 2020 PPP loan of $313,000 was forgiven by the SBA. Pursuant
to ASC 470, Debt, we recorded a gain of $313,000 to extinguish the
PPP loan and accrued interest of $4,000. The Economic Injury
Disaster Loan provides low-interest, long-term financing. We
applied for funding and received (on May 18, 2020) funding in the
amount of $150,000. In March 2021, we applied for funding and were
approved for a second round of Paycheck Protection Program
forgivable financing in the amount of $177,000. In November 2021,
the March 2021 PPP loan of $177,000 was forgiven by the SBA.
Pursuant to ASC 470, Debt, the Company recorded a gain of $177,000
to extinguish the PPP loan and accrued interest of $1,000.
THE OUTBREAK OF THE COVID-19 MAY ADVERSELY AFFECT OUR
CUSTOMERS.
Further, such risks as described above could also adversely affect
our customers’ financial condition, resulting in reduced spending
for the merchandise we sell. Risks related to an epidemic,
pandemic or other health crisis, such as COVID-19, could also lead
to the complete or partial closure of one or more of our facilities
or operations of our sourcing partners. The ultimate extent of
the impact of any epidemic, pandemic or other health crisis on our
business, financial condition and results of operations will depend
on future developments, which are highly uncertain and cannot be
predicted, including new information that may emerge concerning the
severity of such epidemic, pandemic or other health crisis and
actions taken to contain or prevent their further spread,
among others. These and other potential impacts of an
epidemic, pandemic or other health crisis, such as COVID-19, could
therefore materially and adversely affect our business, financial
condition and results of operations.
An economic recession had set in from the pandemic in 2020 and
continued into 2021. Some companies are not receiving payments and
in turn, as a consequence of limited cash flow, are not prepared to
purchase our products. COVID-19 has led to some of our
customers and potential customers being stricken with the virus
causing them to not be able to work for many weeks and therefore
causing delays for us in our marketing decisions. This outbreak
could decrease spending, adversely affect demand for our products,
and harm our business and results of operations. It is not possible
for us to predict the duration or magnitude of the adverse results
of the outbreak or the timing and the degree to which economic
recovery will be realized post-pandemic and, consequently, its
effects on our business or results of operations, financial
condition, or liquidity, at this time.
The global impact of COVID-19 and actions taken to reduce its
spread continues to rapidly evolve and we will continue to monitor
the situation and the effects on our business and operations
closely. We do not yet know the full extent of potential impacts on
our business or operations or on the global economy as a whole,
particularly if the COVID-19 pandemic continues and persists for an
extended period of time. The length of time it may take for global
vaccine distribution and more normal economic and operating
conditions to resume remains uncertain and the economic recovery
period could continue for a prolonged period even after the health
risks of the pandemic subside. Given the uncertainty, we cannot
reasonably estimate the impact on our future results of operations,
cash flows or financial condition. To the extent the ongoing
COVID-19 pandemic adversely affects our business and results of
operations, it may also have the effect of heightening many of the
other risks and uncertainties described in this “Risk Factors”
section of our Annual Report for December 31, 2021 filed with the
SEC on April 14, 2022. We will continue to evaluate the nature and
extent of COVID-19’s impact to our business, consolidated results
of operations, financial condition and liquidity, and our results
presented herein are not necessarily indicative of the results to
be expected for future years.
THE OUTBREAK OF COVID-19 HAS RESULTED IN A WIDESPREAD HEALTH CRISIS
THAT COULD ADVERSELY AFFECT THE ECONOMIES AND FINANCIAL MARKETS
WORLDWIDE AND COULD EXPONENTIALLY INCREASE THE RISK FACTORS
DESCRIBED IN OUR PRIOR FILINGS.
SHOULD ONE OR MORE OF THE FOREGOING RISKS OR UNCERTAINTIES
MATERIALIZE, OR SHOULD THE UNDERLYING ASSUMPTIONS PROVE INCORRECT,
ACTUAL RESULTS MAY DIFFER SIGNIFICANTLY FROM THOSE ANTICIPATED,
BELIEVED, ESTIMATED, EXPECTED, INTENDED OR PLANNED.
ITEM 2. RECENT ISSUANCES OF UNREGISTERED
SECURITIES
In January 2022, we issued a total of 49,383 shares of restricted
common stock, valued at $2,000, to a consultant for services
provided relating to a consultant agreement.
In February 2022, we issued a total of 85,470 shares of restricted
common stock, valued at $4,000, to two consultants for services
provided relating to a consultant agreement.
Subsequent
issuances:
Subsequent to March 31, 2022, we issued 96,083 shares of common
stock for services with a fair value of $4,000.
On May 5, 2022, we entered into Inducement Offer to Exercise Common
Stock Purchase Warrants letter Agreements (the “Exercise
Agreements”) with certain of the holders of the Existing Warrants
to purchase an aggregate of 50,000,000 shares of Common Stock (the
“Exercising Holders”). Pursuant to the Exercise Agreements, the
Exercising Holders and the Company agreed that, subject to any
applicable beneficial ownership limitations, the Exercising Holders
would exercise their Existing Warrants (the “Investor Warrants”)
for shares of Common Stock underlying such Existing Warrants (the
“Exercised Shares”) at a reduced exercise price of $0.02 per share
of Common Stock. In order to induce the Exercising Holders to cash
exercise the Investor Warrants, the Exercise Agreements provide for
the issuance of new warrants to purchase up to an aggregate of
50,000,000 shares of Common Stock (the “New Warrants”), with such
New Warrants to be issued in an amount equal to the number of the
Exercised Shares underlying any Investor Warrants. The New Warrants
are exercisable after issuance, provide for a cashless exercise
provision if the shares of Common Stock underlying the New Warrants
are not registered and terminate on the date that is five years
following the issuance of the New Warrants. The New Warrants have
an exercise price per share of $0.05.
The New Warrants and the shares of Common Stock issuable upon the
exercise of the New Warrants are not being registered under the
Securities Act of 1933 and are being offered pursuant to the
exemption provided in Section 4(a)(2) under the Securities Act of
1933. The Exercised Shares are registered for resale on effective
registration statements previously filed with the Securities and
Exchange Commission.
Subsequent to March 31, 2022, we issued 50,000,000 shares of common
stock for the conversion of 50,000,000 common stock purchase
warrant shares at $0.02 per share for total proceeds of
$1,000,000.
The above offerings, apart from the offerings registered pursuant
to the Securities Act of 1933, were made in reliance upon the
exemption from registration under Rule 506 of Regulation D
promulgated under the Securities Act of 1933 and/or Section 4(2) of
the Securities Act of 1933, based on the following: (a) the
investors confirmed to us that they were “accredited investors,” as
defined in Rule 501 of Regulation D promulgated under the
Securities Act of 1933 and had such background, education and
experience in financial and business matters as to be able to
evaluate the merits and risks of an investment in the securities;
(b) there was no public offering or general solicitation with
respect to the offering; (c) the investors were provided with
certain disclosure materials and all other information requested
with respect to our company; (d) where applicable, the
investors acknowledged that all securities being purchased were
“restricted securities” for purposes of the Securities Act of 1933,
and agreed to transfer such securities only in a transaction
registered under the Securities Act of 1933 or exempt from
registration under the Securities Act; and (e) where
applicable, a legend was placed on the certificates representing
each such security stating that it was restricted and could only be
transferred if subsequent registered under the Securities Act of
1933 or transferred in a transaction exempt from registration under
the Securities Act of 1933.
ITEM 3.
DEFAULTS UPON SENIOR SECURITIES.
At March 31, 2022, the Company is in default on notes payable and
convertible notes payable in the aggregate amount of $2,861,000. We
have not made various principal and interest payments on many of
our debt obligations. We continue to seek work-out arrangements and
applicable refinancing with new or revised debt or equity
instruments. See Notes 2 and 4 to the condensed consolidated
financial statements.
ITEM 4.
MINE SAFETY DISCLOSURES
Not applicable.
ITEM 5.
OTHER INFORMATION.
None.
ITEM 6.
EXHIBITS AND FINANCIAL STATEMENT
SCHEDULES.
Exhibit
Number
|
|
Description
|
1.1
|
|
Placement Agreement dated July 7, 2020, by and between StrikeForce
Technologies, Inc. and Spencer Clarke LLC (23)
|
1.2
|
|
Addendum to Placement Agreement dated November 11, 2020, by and
between StrikeForce Technologies, Inc. and Spencer Clarke LLC
(25)
|
1.3
|
|
Addendum to Placement Agreement dated April 20, 2021, by and
between StrikeForce Technologies, Inc. and Spencer Clarke LLC
(28)
|
3.1
|
|
Amended and Restated Certificate of Incorporation of StrikeForce
Technologies, Inc. (1)
|
3.2
|
|
By-laws of StrikeForce Technologies, Inc. (1)
|
3.3
|
|
Amended By-laws of StrikeForce Technologies, Inc. (2)
|
3.4
|
|
Amended By-laws of StrikeForce Technologies, Inc. (3)
|
3.5
|
|
Articles of Amendment of StrikeForce Technologies, Inc. (2)
|
3.6
|
|
Amendments to Articles of Incorporation (6)
|
3.7
|
|
Amendments to Articles of Incorporation (7)
|
3.8
|
|
Registration of Classes of Securities (8)
|
3.9
|
|
Amendments to Articles of Incorporation (9)
|
3.10
|
|
Registration of Classes of Securities (10)
|
3.11
|
|
Amendments to Articles of Incorporation (11)
|
3.12
|
|
Registration of Classes of Securities (12)
|
3.13
|
|
Amendments to Articles of Incorporation (13)
|
3.14
|
|
Amendments to Articles of Incorporation (14)
|
3.15
|
|
Amendments to Articles of Incorporation (15)
|
3.16
|
|
Amendments to Articles of Incorporation (16)
|
3.17
|
|
Amendments to Articles of Incorporation (17)
|
3.18
|
|
Amendments to Articles of Incorporation (18)
|
3.19
|
|
Amendments to Articles of Incorporation (22)
|
3.20
|
|
Amendments to Articles of Incorporation (26)
|
4.1
|
|
Form of Subscription Agreement (25)
|
4.2
|
|
Form of Convertible Promissory Note-Related Party (24)
|
4.3
|
|
Form of Promissory Note-Related Party (24)
|
4.4
|
|
Form of Warrant (29)
|
10.1
|
|
Employment Agreement dated as of May 20, 2003, by and between
StrikeForce Technologies, Inc. and Mark L. Kay (1)
|
10.2
|
|
Irrevocable Waiver of Conversion Rights of Mark L. Kay (4)
|
10.3
|
|
Irrevocable Waiver of Conversion Rights of Ramarao Pemmaraju
(4)
|
10.4
|
|
Irrevocable Waiver of Conversion Rights of George Waller
(4)
|
10.5
|
|
CFO Consultant Agreement with Philip E. Blocker (4)
|
10.6
|
|
2012 Stock Option Plan (5)
|
10.7
|
|
Asset Purchase Agreement between StrikeForce Technologies, Inc. and
Cyber Safety, Inc., dated August 24, 2015 (18)
|
10.8
|
|
Amendment to the Asset Purchase Agreement and Distributor and
Reseller Agreement between StrikeForce Technologies, Inc. and Cyber
Safety, Inc. (19)
|
10.9
|
|
Execution of Litigation Funding Agreement (20)
|
10.10
|
|
BlockSafe Technologies, Inc. Intellectual Property License
Agreement (21)
|
10.11
|
|
BlockSafe Technologies, Inc. Management Agreement (21)
|
10.12
|
|
BlockSafe Technologies, Inc. Amended Management Agreement
(21)
|
10.13
|
|
Software License and Development Agreement, amendment two, by and
between StrikeForce Technologies, Inc. and Intersections, Inc.,
dated October 1, 2010 (24)
|
10.14
|
|
Form of Settlement and Exchange Agreement (26)
|
10.15
|
|
Cybersecurity Risk Solutions LLC Member Interest Purchase
Agreement, dated April 15, 2021 (27)
|
10.16
|
|
Inducement Offer to Exercise Common Stock Purchase Warrants, dated
May 5, 2022 (29)
|
31.1
|
|
Certification by Chief Executive Officer,
required by Rule 13a-14(a) or Rule 15d-14(a) of the Exchange Act,
promulgated pursuant to Section 302 of the Sarbanes-Oxley Act of
2002. (30)
|
31.2
|
|
Certification by Chief Financial Officer,
required by Rule 13a-14(a) or Rule 15d-14(a) of the Exchange Act,
promulgated pursuant to Section 302 of the Sarbanes-Oxley Act of
2002. (30)
|
32.1
|
|
Certification by Chief Executive Officer,
required by Rule 13a-14(b) or Rule 15d-14(b) of the Exchange Act
and Section 1350 of Chapter 63 of Title 18 of the United States
Code, promulgated pursuant to Section 906 of the Sarbanes-Oxley Act
of 2002. (30)
|
32.2
|
|
Certification by Chief Financial Officer,
required by Rule 13a-14(b) or Rule 15d-14(b) of the Exchange Act
and Section 1350 of Chapter 63 of Title 18 of the United States
Code, promulgated pursuant to Section 906 of the Sarbanes-Oxley Act
of 2002. (30)
|
101.INS
|
|
Inline XBRL Instance Document (the instance document does not
appear in the Interactive Data File because its XBRL tags are
embedded within the Inline XBRL document). (30)
|
101.SCH
|
|
Inline XBRL Taxonomy Extension Schema Document. (30)
|
101.CAL
|
|
Inline XBRL Taxonomy Extension Calculation Linkbase Document.
(30)
|
101.DEF
|
|
Inline XBRL Taxonomy Extension Definition Linkbase Document.
(30)
|
101.LAB
|
|
Inline XBRL Taxonomy Extension Labels Linkbase Document. (30)
|
101.PRE
|
|
Inline XBRL Taxonomy Extension Presentation Linkbase Document.
(30)
|
104
|
|
Cover Page Interactive Data File (formatted as inline XBRL and
contained in Exhibit 101). (30)
|
(1)
|
Filed as an exhibit to the Registrant’s Form SB-2 dated as of May
11, 2005 and incorporated herein by reference.
|
(2)
|
Filed as an exhibit to the Registrant’s Form 8-K dated February 4,
2011 and incorporated herein by reference.
|
(3)
|
Filed as an exhibit to the Registrant’s Form 10-Q dated December
13, 2010 and incorporated herein by reference.
|
(4)
|
Filed as an exhibit to the Registrant’s Form S-1/A dated July 31,
2012 and incorporated herein by reference.
|
(5)
|
Filed in conjunction withthe Registrant’s Form 14A filed October 5,
2012 and incorporated herein by reference.
|
(6)
|
Filed as an exhibit to the Registrant’s Form 8-K dated February 5,
2013 and incorporated herein by reference.
|
(7)
|
Filed as an exhibit to the Registrant’s Form 8-K dated May 14, 2013
and incorporated herein by reference.
|
(8)
|
Filed as an exhibit to the Registrant’s Form 8-A dated July 29,
2013 and incorporated herein by reference.
|
(9)
|
Filed as an exhibit to the Registrant’s Form 8-K dated August 22,
2013 and incorporated herein by reference.
|
(10)
|
Filed as an exhibit to the Registrant’s Form 8-A dated October 3,
2013 and incorporated herein by reference.
|
(11)
|
Filed as an exhibit to the Registrant’s Form 8-K dated October 3,
2013 and incorporated herein by reference.
|
(12)
|
Filed as an exhibit to the Registrant’s Form 8-A dated December 31,
2013 and incorporated herein by reference.
|
(13)
|
Filed as an exhibit to the Registrant’s Form 8-K dated December 31,
2013 and incorporated herein by reference.
|
(14)
|
Filed as an exhibit to the Registrant’s Form 8-K dated March 18,
2014 and incorporated herein by reference.
|
(15)
|
Filed as an exhibit to the Registrant’s Form 8-K dated December 22,
2014 and incorporated herein by reference.
|
(16)
|
Filed as an exhibit to the Registrant’s Form 8-K dated February 13,
2015 and incorporated herein by reference.
|
(17)
|
Filed as an exhibit to the Registrant’s Form 8-K dated August 4,
2015 and incorporated herein by reference.
|
(18)
|
Filed as an exhibit to the Registrant’s Form 8-K dated August 24,
2015 and incorporated herein by reference.
|
(19)
|
Filed as an exhibit to the Registrant’s Form 8-K dated February 2,
2016 and incorporated herein by reference.
|
(20)
|
Filed as an exhibit to the Registrant’s Form 8-K dated September
11, 2017 and incorporated herein by reference.
|
(21)
|
Filed as an exhibit to the Registrant’s Form 10-Q dated June 30,
2018 and incorporated herein by reference.
|
(22)
|
Filed as an exhibit to the Registrant’s Form 8-K dated June 25,
2020 and incorporated herein by reference.
|
(23)
|
Filed as an exhibit to the Registrant’s Form 1-A dated July 13,
2020 and incorporated herein by reference.
|
(24)
|
Filed as an exhibit to the Registrant’s Form 1-A.1 dated September
11, 2020 and incorporated herein by reference.
|
(25)
|
Filed as an exhibit to the Registrant’s Form 1-A.1 dated November
12, 2020 and incorporated herein by reference.
|
(26)
|
Filed as an exhibit to the Registrant’s Form 8-K dated February 8,
2021 and incorporated herein by reference.
|
(27)
|
Filed as an exhibit to the Registrant’s Form 8-K dated April 19,
2021 and incorporated herein by reference.
|
(28)
|
Filed as an exhibit to the Registrant’s Form 1A/A- dated April 26,
2021 and incorporated herein by reference.
|
(29)
|
Filed as an exhibit to the Registrant’s Form 8-K dated May 10, 2022
and incorporated herein by reference
|
(30)
|
Filed herewith.
|
SIGNATURES
In accordance with the requirements of the Exchange Act, the
registrant caused this report to be signed on its behalf by the
undersigned, thereunto duly authorized.
|
STRIKEFORCE TECHNOLOGIES, INC.
|
|
|
|
|
|
Dated: May 23, 2022
|
By:
|
/s/ Mark L. Kay
|
|
|
|
Mark L. Kay
|
|
|
|
Chief Executive Officer
|
|
Dated: May 23, 2022
|
By:
|
/s/ Philip E. Blocker
|
|
|
|
Philip E. Blocker
|
|
|
|
Chief Financial Officer and
Principal Accounting Officer
|
|
Zerify (PK) (USOTC:ZRFY)
Historical Stock Chart
From May 2023 to Jun 2023
Zerify (PK) (USOTC:ZRFY)
Historical Stock Chart
From Jun 2022 to Jun 2023